Charcot-Marie-Tooth Disease X-linked Recessive 4

Genetic MONDO:0010689 Pathograph 22 Show in embeddings browser Charcot-Marie-Tooth Disease

Charcot-Marie-Tooth disease X-linked recessive 4 (CMTX4), also known as Cowchock syndrome, is a rare, slowly progressive X-linked recessive axonal peripheral sensorimotor neuropathy caused by mutations in AIFM1, the gene encoding apoptosis-inducing factor mitochondrion-associated 1 (AIF). The originally described phenotype comprises the triad of axonal motor and sensory neuropathy, sensorineural deafness, and cognitive impairment, with onset from the neonatal period to early childhood. Distal muscle weakness and atrophy predominate in the peroneal (lower-limb) compartment, with pes cavus, areflexia, and a length-dependent stocking-glove sensory deficit. AIFM1 is a mitochondrial FAD-dependent NADH oxidoreductase imported into the intermembrane space, where it supports assembly of the oxidative phosphorylation (OXPHOS) complexes; it also has a distinct pro-apoptotic function when cleaved and released to the nucleus. Because AIFM1 is X-linked, affected individuals are hemizygous males and obligate female carriers are typically asymptomatic. The broader AIFM1 allelic spectrum ranges from this predominantly peripheral-nerve phenotype to severe infantile mitochondrial encephalomyopathy and a cerebellar-ataxia-predominant form (CMTX4 "with cerebellar ataxia").

Ask OpenScientist

Ask a research question about Charcot-Marie-Tooth Disease X-linked Recessive 4. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

1
Inheritance
5
Pathophys.
1
Histopath.
13
Phenotypes
1
Gaps
22
Pathograph
1
Genes
7
Medical Actions
3
References
1
Deep Research
🏷

Classifications

Harrison's Part
NEUROLOGIC
Mechanistic Nosology
mitochondrial disease
👪

Inheritance

1
X-linked Recessive HP:0001419
CMTX4 follows X-linked recessive inheritance: affected individuals are hemizygous males carrying an AIFM1 variant, and obligate female carriers are typically clinically unaffected. Rarely, across the broader AIFM1 allelic spectrum, a heterozygous female can manifest disease when X-linked inactivation is extremely skewed.
X-linked recessive inheritance
Show evidence (3 references)
PMID:8666389 SUPPORT Human Clinical
"Heterozygous females were asymptomatic."
Original Cowchock-family linkage study confirms asymptomatic heterozygous female carriers, consistent with X-linked recessive inheritance.
PMID:31523922 SUPPORT Human Clinical
"Four obligate female carriers were assessed clinically, two of them neurophysiologically; all were unaffected."
Confirms X-linked recessive inheritance with asymptomatic obligate female carriers.
PMID:42329587 SUPPORT Human Clinical
"A heterozygous AIFM1 variant can result in disease manifestation in females."
Documents that, in the broader AIFM1 spectrum, a heterozygous female can manifest disease (via skewed X-inactivation) — a genetic-counseling caveat; the reported female had a severe (encephalomyopathy/cardiomyopathy) phenotype rather than classic CMTX4.
?

Discussions and Knowledge Gaps

1
Does the Harlequin (Hq) mouse — in which AIF is downregulated ~80% — faithfully model CMTX4, given that human CMTX4 is caused by hemizygous AIFM1 missense variants that destabilize AIF and shift its redox/apoptotic behaviour rather than simply reducing AIF expression, and given that the Hq mouse phenotype is dominated by central (cerebellar/thalamic/striatal/cortical) and retinal neurodegeneration rather than the human peripheral-neuropathy-plus-deafness presentation?
HUMAN MODEL MISMATCH OPEN mismatch_harlequin_knockdown_vs_human_missense
Attached to
pathophysiology#Mitochondrial Dysfunction in Peripheral Neurons pathophysiology#Impaired Mitochondrial OXPHOS Complex Assembly
The principal in vivo AIF model, the Harlequin mouse (PMID:17805014), is a loss-of-expression (knockdown) model producing severe complex I deficiency and progressive multifocal CNS neurodegeneration. Human CMTX4, by contrast, is caused by missense variants (e.g., p.Glu493Val, p.Glu336Lys) that in the classic phenotype do NOT cause overt respiratory-chain failure (PMID:23217327) but instead destabilize AIF, weaken the AIF:CHCHD4/MIA40 import interaction, and perturb supercomplex assembly (PMID:41957773). Whether a knockdown model that removes AIF recapitulates the redox-shift, partial-loss-of-function mechanism of the human missense disease — and its peripheral-nerve/auditory-neuron tropism — is an open translational question.
Proposed experiments
Knock-in mouse / iPSC neuron models of human CMTX4 missense variants
exp_aifm1_knockin_peripheral_vs_central
Generate knock-in mice and/or patient-derived iPSC motor and sensory neurons carrying specific human CMTX4 missense alleles (e.g., p.Glu493Val, p.Glu336Lys) to model the redox-shift mechanism rather than AIF deficiency, and directly compare peripheral-nerve versus central/retinal vulnerability against the Harlequin knockdown phenotype.
Seeded from the OpenScientist deep-research report (2026-07-31), which flagged that the dominant animal model is a knockdown emphasizing central/retinal phenotypes and does not knock in the human CMTX4 missense alleles.
⚙

Pathophysiology

5
Altered AIF Redox Function
CMTX4 is caused by hemizygous missense mutations in AIFM1, encoding apoptosis-inducing factor (AIF), an FAD-dependent NADH oxidoreductase imported into the mitochondrial intermembrane space. The founding p.Glu493Val mutation lies at a highly conserved residue and alters the redox properties of AIF without impairing the enzymatic activity of the respiratory chain complexes — implicating a change in AIF's redox behaviour rather than a simple loss of OXPHOS enzyme activity. This redox-switch perturbation forks downstream into two arms: loss of the AIF-dependent mitochondrial import/assembly function, and a shift toward increased (caspase-independent) apoptotic cell death.
AIFM1 hgnc:8768 HUGO Gene Nomenclature Committee (hgnc) Relation: this pathophysiological event involves this gene This pathophysiological event involves AIFM1 (hgnc:8768). hgnc:8768 is a gene from the HUGO Gene Nomenclature Committee.
NADH oxidoreductase activity GO:0003954 Gene Ontology (GO) Relation: this pathophysiological event involves this molecular function This pathophysiological event involves NADH oxidoreductase activity, annotated with NADH dehydrogenase activity (GO:0003954). GO:0003954 is a molecular function from the Gene Ontology.
Downstream
Impaired Mitochondrial OXPHOS Complex Assembly AIF supports import-dependent assembly of the mitochondrial respiratory chain; pathogenic AIFM1 variants perturb this function in peripheral neurons.
Increased Caspase-Independent Neuronal Apoptosis The redox-switch shift promotes AIF's pro-apoptotic activity, driving neuronal cell death independent of any respiratory-chain enzyme deficit.
Show evidence (2 references)
PMID:23217327 SUPPORT Human Clinical
"Exome sequencing of an affected individual from the originally described family identified a missense change c.1478A>T (p.Glu493Val) in AIFM1, the gene encoding apoptosis-inducing factor (AIF) mitochondrion-associated 1."
Identifies the founding AIFM1 p.Glu493Val mutation as the cause of Cowchock syndrome/CMTX4.
PMID:23217327 SUPPORT In Vitro
"The c.1478A>T (p.Glu493Val) mutation found in the family reported here alters the redox properties of the AIF protein and results in increased cell death via apoptosis, without affecting the activity of the respiratory chain complexes."
Establishes that the Cowchock mutation acts by altering AIF redox properties and increasing apoptosis rather than by directly impairing respiratory chain enzyme activity.
Increased Caspase-Independent Neuronal Apoptosis
The parallel (pro-apoptotic) arm of AIF dysfunction: the redox-shifted mutant protein increases caspase-independent apoptotic cell death in vulnerable neuronal populations. In auditory (spiral ganglion) neurons this apoptosis is driven by impaired AIF dimerization, giving the neural (auditory neuropathy) hearing loss; the same pro-apoptotic tendency contributes to the central (cerebellar/cortical) and retinal vulnerability seen across the AIFM1 spectrum.
Spiral ganglion (auditory) neuron CL:0011113 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves Spiral ganglion (auditory) neuron, annotated with spiral ganglion neuron (CL:0011113). CL:0011113 is a cell type from the Cell Ontology. Sensory neuron CL:0000101 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves Sensory neuron (CL:0000101). CL:0000101 is a cell type from the Cell Ontology. Motor neuron CL:0000100 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves Motor neuron (CL:0000100). CL:0000100 is a cell type from the Cell Ontology.
Apoptotic process GO:0006915 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves increased Apoptotic process (GO:0006915). GO:0006915 is a biological process from the Gene Ontology. ↑ INCREASED
Downstream
Sensorineural Hearing Impairment Apoptosis of spiral ganglion / auditory neurons produces the neural (auditory neuropathy) sensorineural deafness of the Cowchock triad.
Cognitive Impairment Central neuronal apoptosis contributes to the cognitive impairment of the classic Cowchock triad.
Cerebellar Ataxia Cerebellar neuronal loss underlies the ataxia seen in the cerebellar-predominant part of the AIFM1/CMTX4 spectrum.
Abnormal Pyramidal Sign Corticospinal (upper motor neuron) involvement from central neuronal loss produces the pyramidal signs reported in part of the AIFM1/CMTX4 spectrum.
Tremor Central movement-network (basal-ganglia/striatal) neuronal vulnerability contributes to the tremor reported in a subset of AIFM1/CMTX4 patients.
Color Vision Deficiency Central visual-pathway neuronal vulnerability is the proposed basis of the rare colour-vision deficiency reported in the spectrum.
Show evidence (2 references)
PMID:23217327 SUPPORT In Vitro
"results in increased cell death via apoptosis, without affecting the activity of the respiratory chain complexes."
The founding CMTX4 mutation increases apoptotic cell death independent of respiratory-chain enzyme activity, establishing the pro-apoptotic arm.
PMID:36751702 SUPPORT In Vitro
"AIFM1 variants associated with auditory neuropathy spectrum disorder cause apoptosis due to impaired apoptosis-inducing factor dimerization."
In AIF-mutant auditory-neuron cell models, AIFM1 variants cause apoptosis via impaired AIF dimerization, mechanistically linking the pro-apoptotic arm to the auditory-neuropathy deafness.
Impaired Mitochondrial OXPHOS Complex Assembly
AIFM1 forms a redox-regulated complex with the mitochondrial intermembrane space import and assembly protein MIA40 (CHCHD4), and deficiency of either protein impairs assembly of mitochondrial respiratory complex I (and complex IV). A neuropathy-associated AIFM1 missense mutation (p.Phe210Leu) caused abnormal assembly of mitochondrial complexes I and III, providing a mechanistic link between AIFM1 dysfunction and defective oxidative phosphorylation in affected peripheral nerve.
AIFM1 hgnc:8768 HUGO Gene Nomenclature Committee (hgnc) Relation: this pathophysiological event involves this gene This pathophysiological event involves AIFM1 (hgnc:8768). hgnc:8768 is a gene from the HUGO Gene Nomenclature Committee.
Mitochondrial respiratory chain complex I assembly GO:0032981 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal Mitochondrial respiratory chain complex I assembly (GO:0032981). GO:0032981 is a biological process from the Gene Ontology. ⚠ ABNORMAL Protein import into mitochondrial intermembrane space GO:0045041 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal Protein import into mitochondrial intermembrane space (GO:0045041). GO:0045041 is a biological process from the Gene Ontology. ⚠ ABNORMAL
Downstream
Mitochondrial Dysfunction in Peripheral Neurons Misassembled OXPHOS complexes reduce the mitochondrial energy supply available to metabolically demanding peripheral axons.
Show evidence (4 references)
PMID:28888069 SUPPORT In Vitro
"this Phe210Leu mutation resulted in abnormal assembly of mitochondrial complex I and III, and failed to disrupt AIFM1 binding with mitochondrial intermembrane space import and assembly protein 40 (MIA40) in the patients' cells."
Patient fibroblast study showing a CMTX4-associated AIFM1 mutation causes misassembly of OXPHOS complexes I and III.
PMID:28888069 SUPPORT In Vitro
"Deficiency of either AIFM1 or MIA40 is known to impair the assembly of mitochondrial complex I and IV."
Establishes the AIFM1/MIA40 axis as required for assembly of mitochondrial respiratory complexes.
PMID:41957773 SUPPORT In Vitro
"Patient-derived fibroblasts exhibited reduced AIF protein stability despite preserved mRNA expression, impaired growth in OXPHOS-dependent conditions, decreased basal respiration, and altered assembly of mitochondrial respiratory supercomplexes."
CMTX4 (E336K) patient fibroblasts show reduced AIF stability, impaired respiration, and altered respiratory supercomplex assembly.
+ 1 more reference
Mitochondrial Dysfunction in Peripheral Neurons
AIFM1 dysfunction produces abnormal mitochondrial morphology and accumulation within the axoplasm of peripheral nerve fibres and the subsarcolemmal region of muscle, reflecting disturbed mitochondrial homeostasis in the long peripheral neurons that are most dependent on sustained mitochondrial energy supply and transport.
Motor neuron CL:0000100 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves Motor neuron (CL:0000100). CL:0000100 is a cell type from the Cell Ontology. Sensory neuron CL:0000101 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves Sensory neuron (CL:0000101). CL:0000101 is a cell type from the Cell Ontology.
Apoptotic process GO:0006915 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves increased Apoptotic process (GO:0006915). GO:0006915 is a biological process from the Gene Ontology. ↑ INCREASED
Downstream
Distal Axonal Degeneration Neuronal mitochondrial dysfunction drives length-dependent dying-back degeneration of the longest peripheral axons.
Show evidence (2 references)
PMID:30031633 SUPPORT Human Clinical
"Pathologies exhibited abnormal mitochondrial morphology and accumulation in axoplasm of nerve fiber and subsarcolemmal area of muscle."
Nerve/muscle pathology in a CMTX4 family shows abnormal mitochondrial morphology and axoplasmic accumulation, linking AIFM1 mutation to neuronal mitochondrial dysfunction.
PMID:17805014 SUPPORT Model Organism
"degenerating mitochondria were observed in most cells in these structures, even in nondegenerating neurons, a finding that indicates mitochondrial injury is a cause rather than an effect of neuronal cell death."
Harlequin (AIF-downregulated) mouse model shows mitochondrial injury precedes and causes neuronal death, supporting mitochondrial dysfunction as the primary driver of AIF-related neurodegeneration.
Distal Axonal Degeneration
The final common pathway in CMTX4 is length-dependent axonal degeneration of peripheral nerves, producing a large-fibre sensorimotor axonal neuropathy. The longest axons — those of the distal lower limbs — are affected first, yielding the characteristic distal-predominant weakness, atrophy, and sensory loss.
Motor neuron CL:0000100 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves Motor neuron (CL:0000100). CL:0000100 is a cell type from the Cell Ontology. Sensory neuron CL:0000101 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves Sensory neuron (CL:0000101). CL:0000101 is a cell type from the Cell Ontology.
Downstream
Peripheral Axonal Neuropathy
Distal Muscle Weakness
Distal Sensory Impairment
Distal Lower Limb Amyotrophy
Pes Cavus
Hammertoe
Areflexia
Show evidence (1 reference)
PMID:31523922 SUPPORT Human Clinical
"Neurophysiology demonstrated length-dependent large-fibre sensorimotor axonal neuropathy, with particular involvement of superficial radial sensory responses."
Neurophysiology in an AIFM1/CMTX4 family confirms a length-dependent large-fibre sensorimotor axonal neuropathy as the core lesion.
✶

Histopathology

1
Sural Nerve and Muscle Mitochondrial Pathology
Nerve and muscle biopsy in CMTX4 shows abnormal mitochondrial morphology with accumulation of mitochondria in the axoplasm of nerve fibres and in the subsarcolemmal region of muscle, the tissue correlate of the mitochondrial dysfunction driven by AIFM1 mutation.
Show evidence (1 reference)
PMID:30031633 SUPPORT Human Clinical
"Pathologies exhibited abnormal mitochondrial morphology and accumulation in axoplasm of nerve fiber and subsarcolemmal area of muscle."
Nerve/muscle histopathology shows abnormal mitochondrial morphology and axoplasmic/subsarcolemmal mitochondrial accumulation in CMTX4.
⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.
Pathograph: causal mechanism network for Charcot-Marie-Tooth Disease X-linked Recessive 4 Interactive directed graph showing how pathophysiology mechanisms, phenotypes, genetic factors and variants, experimental models, environmental triggers, and treatments relate through causal and linked edges.
●

Phenotypes

13
Ear 1
Sensorineural Hearing Impairment FREQUENT HP:0000407 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Sensorineural hearing impairment (HP:0000407). HP:0000407 is a phenotype from the Human Phenotype Ontology.
Show evidence (3 references)
PMID:23217327 SUPPORT Human Clinical
"Cowchock syndrome (CMTX4) is a slowly progressive X-linked recessive disorder with axonal neuropathy, deafness, and cognitive impairment."
Establishes sensorineural deafness as a core component of the CMTX4/Cowchock phenotype.
PMID:31523922 SUPPORT Human Clinical
"All developed variably present sensorineural deafness, peripheral neuropathy, cerebellar ataxia, and pyramidal involvement."
Confirms variably present sensorineural deafness in an AIFM1/CMTX4 family.
PMID:8666389 SUPPORT Human Clinical
"Five of the seven affected males showed associated deafness, and three of these five individuals also presented with mental retardation or social developmental delay."
Quantifies deafness (5/7 affected males) in the original Cowchock family, supporting a FREQUENT frequency band.
Eye 1
Color Vision Deficiency VERY_RARE Color vision defect HP:0000551 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Color vision defect (HP:0000551). HP:0000551 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:31523922 SUPPORT Human Clinical
"In addition, three had colour vision deficiency."
Documents colour-vision deficiency in three affected males of the Irish AIFM1/CMTX4 family.
Limbs 1
Pes Cavus VERY_FREQUENT HP:0001761 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Pes cavus (HP:0001761). HP:0001761 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:8666389 SUPPORT Human Clinical
"The patients were severely affected within the first few years of life with distal weakness, muscle atrophy, sensory loss, areflexia, pes cavus, and hammer toes."
All seven affected males of the original Cowchock family had pes cavus, supporting a VERY_FREQUENT band.
Musculoskeletal 1
Distal Muscle Weakness VERY_FREQUENT HP:0002460 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Distal muscle weakness (HP:0002460), qualified as course progressive. HP:0002460 is a phenotype from the Human Phenotype Ontology.
Course: PROGRESSIVE
Show evidence (2 references)
PMID:30031633 SUPPORT Human Clinical
"we report a novel missense variant of AIFM1 in a X-linked recessive Chinese family with childhood-onset, slowly progressive, isolated axonal motor and sensory neuropathy."
Documents childhood-onset slowly progressive motor (and sensory) neuropathy in a CMTX4 family.
PMID:8666389 SUPPORT Human Clinical
"The patients were severely affected within the first few years of life with distal weakness, muscle atrophy, sensory loss, areflexia, pes cavus, and hammer toes."
All seven affected males of the original Cowchock family had early distal weakness, supporting a VERY_FREQUENT band.
Nervous System 4
Cognitive Impairment OCCASIONAL HP:0100543 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Cognitive impairment (HP:0100543). HP:0100543 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:23217327 SUPPORT Human Clinical
"Cowchock syndrome (CMTX4) is a slowly progressive X-linked recessive disorder with axonal neuropathy, deafness, and cognitive impairment."
Establishes cognitive impairment as part of the original Cowchock triad.
PMID:31523922 SUPPORT Human Clinical
"All individuals had normal cognitive assessment."
Documents preserved cognition in one large AIFM1 family, supporting the variable/occasional nature of cognitive impairment in the spectrum.
Areflexia VERY_FREQUENT HP:0001284 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Areflexia (HP:0001284). HP:0001284 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:8666389 SUPPORT Human Clinical
"The patients were severely affected within the first few years of life with distal weakness, muscle atrophy, sensory loss, areflexia, pes cavus, and hammer toes."
All seven affected males of the original Cowchock family had areflexia, supporting a VERY_FREQUENT band.
Cerebellar Ataxia OCCASIONAL Progressive cerebellar ataxia HP:0002073 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Progressive cerebellar ataxia (HP:0002073). HP:0002073 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:31523922 SUPPORT Human Clinical
"All developed variably present sensorineural deafness, peripheral neuropathy, cerebellar ataxia, and pyramidal involvement."
Documents cerebellar ataxia and pyramidal involvement within the AIFM1/CMTX4 clinical spectrum.
Tremor OCCASIONAL HP:0001337 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Tremor (HP:0001337). HP:0001337 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:36907087 SUPPORT Human Clinical
"Both individuals had a progressive complex movement disorder phenotype, including disabling tremor poorly responsive to medications."
Documents disabling, medication-refractory tremor in two brothers with a Cowchock-syndrome AIFM1 variant.
Other 5
Peripheral Axonal Neuropathy OBLIGATE HP:0003477 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Peripheral axonal neuropathy (HP:0003477), qualified as course progressive; childhood onset. HP:0003477 is a phenotype from the Human Phenotype Ontology.
Course: PROGRESSIVE Onset: CHILDHOOD
Show evidence (1 reference)
PMID:23217327 SUPPORT Human Clinical
"Cowchock syndrome (CMTX4) is a slowly progressive X-linked recessive disorder with axonal neuropathy, deafness, and cognitive impairment."
Defines the CMTX4 core phenotype as a slowly progressive axonal neuropathy.
Distal Sensory Impairment VERY_FREQUENT HP:0002936 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Distal sensory impairment (HP:0002936). HP:0002936 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:31523922 SUPPORT Human Clinical
"Neurophysiology demonstrated length-dependent large-fibre sensorimotor axonal neuropathy, with particular involvement of superficial radial sensory responses."
Confirms the sensory axonal component of the length-dependent neuropathy in CMTX4.
PMID:8666389 SUPPORT Human Clinical
"The patients were severely affected within the first few years of life with distal weakness, muscle atrophy, sensory loss, areflexia, pes cavus, and hammer toes."
All seven affected males of the original Cowchock family had sensory loss, supporting a VERY_FREQUENT band.
Distal Lower Limb Amyotrophy VERY_FREQUENT HP:0008944 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Distal lower limb amyotrophy (HP:0008944). HP:0008944 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:30031633 SUPPORT Human Clinical
"Calf magnetic resonance imaging revealed fatty infiltration and atrophy severely involving the muscles of peroneal compartment."
MRI documents peroneal-predominant muscle atrophy/fatty infiltration in a CMTX4 family.
PMID:8666389 SUPPORT Human Clinical
"The patients were severely affected within the first few years of life with distal weakness, muscle atrophy, sensory loss, areflexia, pes cavus, and hammer toes."
All seven affected males of the original Cowchock family had muscle atrophy, supporting a VERY_FREQUENT band.
Hammertoe VERY_FREQUENT HP:0001765 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Hammertoe (HP:0001765). HP:0001765 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:8666389 SUPPORT Human Clinical
"The patients were severely affected within the first few years of life with distal weakness, muscle atrophy, sensory loss, areflexia, pes cavus, and hammer toes."
All seven affected males of the original Cowchock family had hammer toes, supporting a VERY_FREQUENT band.
Abnormal Pyramidal Sign OCCASIONAL HP:0007256 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Abnormal pyramidal sign (HP:0007256). HP:0007256 is a phenotype from the Human Phenotype Ontology.
Frequency banded consistently with cerebellar ataxia (OCCASIONAL), since both derive from the same variably-present PMID:31523922 clinical clause.
Show evidence (1 reference)
PMID:31523922 SUPPORT Human Clinical
"All developed variably present sensorineural deafness, peripheral neuropathy, cerebellar ataxia, and pyramidal involvement."
Documents pyramidal involvement in an AIFM1/CMTX4 family.
🧬

Genetic Associations

1
AIFM1 (Causative)
Gene: AIFM1 hgnc:8768 HUGO Gene Nomenclature Committee (hgnc) Relation: this disease-associated gene is this gene This disease-associated gene is AIFM1 (hgnc:8768). hgnc:8768 is a gene from the HUGO Gene Nomenclature Committee.
Show evidence (3 references)
PMID:23217327 SUPPORT Human Clinical
"The change is at a highly conserved residue and cosegregated with the phenotype in the family."
Cosegregation of the AIFM1 p.Glu493Val variant with the CMTX4 phenotype supports causality.
PMID:37173762 SUPPORT Human Clinical
"The apoptosis-inducing factor mitochondria associated-1 (AIFM1) is the main pathogenic gene of the X-linked recessive Charcot-Marie-Tooth disease-4 with or without cerebellar ataxia (CMTX4), also known as Cowchock syndrome."
Confirms AIFM1 as the causative gene of CMTX4/Cowchock syndrome.
PMID:41957773 SUPPORT Human Clinical
"we identified and comprehensively characterized a novel hemizygousAIFM1mutation c.1006G > A (E336K) in a male patient presenting with a progressive hereditary axonal sensorimotor polyneuropathy with childhood onset, inherited in an X-linked recessive pattern, associated with sensorineural..."
Adds a functionally characterized AIFM1 CMTX4 variant (E336K) with the classic axonal neuropathy plus deafness phenotype.
💊

Medical Actions

7
Physical Therapy and Rehabilitation
Action: physical therapyNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is physical therapy (NCIT:C15302). NCIT:C15302 is a clinical intervention from the NCI Thesaurus. Ontology label: Physical Therapy NCIT:C15302
Supportive physiotherapy to maintain strength, flexibility, and gait, as for other forms of Charcot-Marie-Tooth disease; no disease-modifying therapy is currently available for CMTX4.
Orthotic Devices
Action: orthotic supportive careNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is orthotic supportive care, annotated with Supportive Care (NCIT:C15747). NCIT:C15747 is a clinical intervention from the NCI Thesaurus. Ontology label: Supportive Care NCIT:C15747
Ankle-foot orthoses to compensate for foot drop and improve gait stability, with orthopedic footwear for foot deformities.
Hearing Rehabilitation
Action: supportive careNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is supportive care (NCIT:C15747). NCIT:C15747 is a clinical intervention from the NCI Thesaurus. Ontology label: Supportive Care NCIT:C15747
Management of sensorineural deafness with hearing aids, addressing the auditory component of the Cowchock phenotype. Because the hearing loss in the AIFM1 spectrum is a neural (auditory neuropathy spectrum disorder / DFNX5) phenomenon rather than pure cochlear loss, device selection is guided by audiologic (ABR) characterisation.
Show evidence (1 reference)
PMID:36751702 SUPPORT Other
"Auditory neuropathy spectrum disorder (ANSD) represents a variety of sensorineural deafness conditions characterized by abnormal inner hair cells and/or auditory nerve function, but with the preservation of outer hair cell function."
Establishes that AIFM1-associated deafness is an auditory neuropathy (neural) phenotype, informing hearing-rehabilitation choice.
Cochlear Implantation
Action: cochlear implantationNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is cochlear implantation, annotated with Surgical Procedure (NCIT:C15329). NCIT:C15329 is a clinical intervention from the NCI Thesaurus. Ontology label: Surgical Procedure NCIT:C15329
Cochlear implantation may be considered for the auditory-neuropathy hearing loss of the AIFM1 spectrum when conventional amplification is inadequate, stimulating the cochlear nerve directly.
Target Phenotypes: Sensorineural hearing impairment HP:0000407 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Sensorineural hearing impairment (HP:0000407). HP:0000407 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:36751702 SUPPORT Other
"Auditory neuropathy spectrum disorder (ANSD) represents a variety of sensorineural deafness conditions characterized by abnormal inner hair cells and/or auditory nerve function, but with the preservation of outer hair cell function."
The neural (auditory-neuropathy) character of AIFM1 deafness is the rationale for considering cochlear implantation over amplification in selected patients.
Orthopedic Surgery for Foot Deformity
Action: orthopedic surgical procedureNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is orthopedic surgical procedure (NCIT:C16186). NCIT:C16186 is a clinical intervention from the NCI Thesaurus. Ontology label: Orthopedic Surgical Procedure NCIT:C16186
Corrective orthopedic surgery (e.g., tendon transfers, osteotomies) for severe pes cavus and hammer-toe deformities when conservative measures fail to maintain functional ambulation.
Target Phenotypes: Pes cavus HP:0001761 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Pes cavus (HP:0001761). HP:0001761 is a phenotype from the Human Phenotype Ontology. Hammertoe HP:0001765 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Hammertoe (HP:0001765). HP:0001765 is a phenotype from the Human Phenotype Ontology.
Genetic Counseling
Action: Genetic CounselingNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Genetic Counseling (NCIT:C15240). NCIT:C15240 is a clinical intervention from the NCI Thesaurus. NCIT:C15240
Genetic counseling for X-linked recessive inheritance, including carrier testing of at-risk female relatives and reproductive counseling.
Show evidence (2 references)
PMID:37173762 SUPPORT Human Clinical
"The results of our study may also be useful for genetic counseling, embryo screening of in vitro fertilization embryos, and prenatal genetic diagnosis."
Supports genetic counseling and reproductive options for families with AIFM1/CMTX4.
PMID:20301532 SUPPORT Other
"Inform genetic counseling of family members of an individual with CMT hereditary neuropathy."
The GeneReviews CMT overview (baseline reference; no CMTX4-specific GeneReviews exists) includes genetic counseling of family members as standard CMT management.
🔬

Diagnosis

4
Nerve Conduction Studies and Electromyography
Neurophysiology demonstrates a length-dependent, large-fibre sensorimotor axonal neuropathy with reduced sensory and motor amplitudes and relatively preserved conduction velocities (axonal pattern). Particular involvement of the superficial radial sensory response has been proposed as a phenotypic marker.
Show evidence (1 reference)
PMID:31523922 SUPPORT Human Clinical
"Superficial radial nerve was particularly affected neurophysiologically, which could represent a phenotypic marker towards this specific genetic diagnosis."
Describes the axonal neurophysiology and a candidate phenotypic marker useful for diagnosis.
Molecular Genetic Testing
Diagnosis is confirmed by identification of a hemizygous pathogenic AIFM1 variant, typically via exome or whole-genome sequencing in a male with X-linked recessive axonal neuropathy with or without deafness, cognitive impairment, or cerebellar ataxia.
Show evidence (1 reference)
PMID:23217327 SUPPORT Human Clinical
"Exome sequencing of an affected individual from the originally described family identified a missense change c.1478A>T (p.Glu493Val) in AIFM1, the gene encoding apoptosis-inducing factor (AIF) mitochondrion-associated 1."
Establishes AIFM1 sequencing as the molecular diagnostic approach for CMTX4.
Audiologic Evaluation
Audiometry with auditory brainstem response (ABR) testing characterises the hearing loss as an auditory neuropathy pattern — abnormal auditory-nerve / inner-hair-cell function with preserved outer hair cell (otoacoustic emission) responses — which distinguishes the neural deafness of the AIFM1 spectrum from ordinary cochlear loss and guides rehabilitation choice.
Show evidence (1 reference)
PMID:36751702 SUPPORT Other
"Auditory neuropathy spectrum disorder (ANSD) represents a variety of sensorineural deafness conditions characterized by abnormal inner hair cells and/or auditory nerve function, but with the preservation of outer hair cell function."
Defines the auditory-neuropathy audiologic pattern (abnormal auditory nerve with preserved outer hair cells) that characterises AIFM1-associated deafness.
Muscle MRI
Calf muscle MRI shows fatty infiltration and atrophy with a peroneal-compartment predominance, supporting the length-dependent motor phenotype.
Show evidence (1 reference)
PMID:30031633 SUPPORT Human Clinical
"Calf magnetic resonance imaging revealed fatty infiltration and atrophy severely involving the muscles of peroneal compartment."
Calf MRI documents the peroneal-predominant fatty infiltration/atrophy pattern useful in the diagnostic workup.
📈

Progression

1
Overall course
Duration: Lifelong
Slowly progressive, chronic, lifelong course with onset from the neonatal period to early childhood in the classic form (reported spectrum ~18 months to ~39 years); no relapsing-remitting pattern or spontaneous remission.
Show evidence (1 reference)
PMID:23217327 SUPPORT Human Clinical
"Cowchock syndrome (CMTX4) is a slowly progressive X-linked recessive disorder with axonal neuropathy, deafness, and cognitive impairment."
Establishes the slowly progressive course of CMTX4.
📊

Prevalence

1
Worldwide
Cases In Literature Not yet documented
CMTX4 is an ultra-rare AIFM1 subtype of Charcot-Marie-Tooth disease described in only a small number of families worldwide (the original US family plus Irish, Chinese, Spanish, and other kindreds); no formal prevalence or incidence figure has been established.
{ }

Source YAML

click to show 
name: Charcot-Marie-Tooth Disease X-linked Recessive 4
creation_date: "2026-07-31T00:00:00Z"
category: Genetic
description: >
  Charcot-Marie-Tooth disease X-linked recessive 4 (CMTX4), also known as
  Cowchock syndrome, is a rare, slowly progressive X-linked recessive axonal
  peripheral sensorimotor neuropathy caused by mutations in AIFM1, the gene
  encoding apoptosis-inducing factor mitochondrion-associated 1 (AIF). The
  originally described phenotype comprises the triad of axonal motor and
  sensory neuropathy, sensorineural deafness, and cognitive impairment, with
  onset from the neonatal period to early childhood. Distal muscle weakness
  and atrophy predominate in the peroneal (lower-limb) compartment, with pes
  cavus, areflexia, and a length-dependent stocking-glove sensory deficit.
  AIFM1 is a mitochondrial FAD-dependent NADH oxidoreductase imported into the
  intermembrane space, where it supports assembly of the oxidative
  phosphorylation (OXPHOS) complexes; it also has a distinct pro-apoptotic
  function when cleaved and released to the nucleus. Because AIFM1 is
  X-linked, affected individuals are hemizygous males and obligate female
  carriers are typically asymptomatic. The broader AIFM1 allelic spectrum
  ranges from this predominantly peripheral-nerve phenotype to severe infantile
  mitochondrial encephalomyopathy and a cerebellar-ataxia-predominant form
  (CMTX4 "with cerebellar ataxia").
disease_term:
  preferred_term: Charcot-Marie-Tooth disease X-linked recessive 4
  term:
    id: MONDO:0010689
    label: Charcot-Marie-Tooth disease X-linked recessive 4
parents:
- Charcot-Marie-Tooth Disease
synonyms:
- Cowchock syndrome
- CMTX4
- CMT4X
- Neuropathy, axonal motor-sensory, with deafness and intellectual disability

classifications:
  harrisons_chapter:
  - classification_value: NEUROLOGIC
    notes: >-
      Inherited peripheral neuropathy (Charcot-Marie-Tooth disease) with
      associated sensorineural deafness and CNS features — a neurologic /
      neuromuscular disorder.
  mechanistic_category:
  - classification_value: mitochondrial disease
    notes: >-
      Caused by mutations in AIFM1, encoding the mitochondrial
      intermembrane-space flavoprotein AIF; pathogenesis involves impaired AIF-dependent
      mitochondrial import/respiratory-complex assembly and increased
      mitochondrial apoptosis.

pathophysiology:
- name: Altered AIF Redox Function
  biological_scale: MOLECULAR
  description: >
    CMTX4 is caused by hemizygous missense mutations in AIFM1, encoding
    apoptosis-inducing factor (AIF), an FAD-dependent NADH oxidoreductase
    imported into the mitochondrial intermembrane space. The founding
    p.Glu493Val mutation lies at a highly conserved residue and alters the
    redox properties of AIF without impairing the enzymatic activity of the
    respiratory chain complexes — implicating a change in AIF's redox behaviour
    rather than a simple loss of OXPHOS enzyme activity. This redox-switch
    perturbation forks downstream into two arms: loss of the AIF-dependent
    mitochondrial import/assembly function, and a shift toward increased
    (caspase-independent) apoptotic cell death.
  genes:
  - preferred_term: AIFM1
    term:
      id: hgnc:8768
      label: AIFM1
  molecular_functions:
  - preferred_term: NADH oxidoreductase activity
    term:
      id: GO:0003954
      label: NADH dehydrogenase activity
  downstream:
  - target: Impaired Mitochondrial OXPHOS Complex Assembly
    description: >
      AIF supports import-dependent assembly of the mitochondrial respiratory
      chain; pathogenic AIFM1 variants perturb this function in peripheral
      neurons.
  - target: Increased Caspase-Independent Neuronal Apoptosis
    description: >
      The redox-switch shift promotes AIF's pro-apoptotic activity, driving
      neuronal cell death independent of any respiratory-chain enzyme deficit.
  evidence:
  - reference: PMID:23217327
    reference_title: "Cowchock syndrome is associated with a mutation in apoptosis-inducing factor."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Exome sequencing of an affected individual from the originally described family identified a missense change c.1478A>T (p.Glu493Val) in AIFM1, the gene encoding apoptosis-inducing factor (AIF) mitochondrion-associated 1."
    explanation: Identifies the founding AIFM1 p.Glu493Val mutation as the cause of Cowchock syndrome/CMTX4.
  - reference: PMID:23217327
    reference_title: "Cowchock syndrome is associated with a mutation in apoptosis-inducing factor."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "The c.1478A>T (p.Glu493Val) mutation found in the family reported here alters the redox properties of the AIF protein and results in increased cell death via apoptosis, without affecting the activity of the respiratory chain complexes."
    explanation: Establishes that the Cowchock mutation acts by altering AIF redox properties and increasing apoptosis rather than by directly impairing respiratory chain enzyme activity.

- name: Increased Caspase-Independent Neuronal Apoptosis
  biological_scale: CELLULAR
  description: >
    The parallel (pro-apoptotic) arm of AIF dysfunction: the redox-shifted
    mutant protein increases caspase-independent apoptotic cell death in
    vulnerable neuronal populations. In auditory (spiral ganglion) neurons this
    apoptosis is driven by impaired AIF dimerization, giving the neural
    (auditory neuropathy) hearing loss; the same pro-apoptotic tendency
    contributes to the central (cerebellar/cortical) and retinal vulnerability
    seen across the AIFM1 spectrum.
  cell_types:
  - preferred_term: Spiral ganglion (auditory) neuron
    term:
      id: CL:0011113
      label: spiral ganglion neuron
  - preferred_term: Sensory neuron
    term:
      id: CL:0000101
      label: sensory neuron
  - preferred_term: Motor neuron
    term:
      id: CL:0000100
      label: motor neuron
  biological_processes:
  - preferred_term: Apoptotic process
    term:
      id: GO:0006915
      label: apoptotic process
    modifier: INCREASED
  downstream:
  - target: Sensorineural Hearing Impairment
    description: >
      Apoptosis of spiral ganglion / auditory neurons produces the neural
      (auditory neuropathy) sensorineural deafness of the Cowchock triad.
  - target: Cognitive Impairment
    description: >
      Central neuronal apoptosis contributes to the cognitive impairment of the
      classic Cowchock triad.
  - target: Cerebellar Ataxia
    description: >
      Cerebellar neuronal loss underlies the ataxia seen in the
      cerebellar-predominant part of the AIFM1/CMTX4 spectrum.
    evidence:
    - reference: PMID:17805014
      reference_title: "Apoptosis-inducing factor deficiency induces early mitochondrial degeneration in brain followed by progressive multifocal neuropathology."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "Neurodegeneration was not restricted to the cerebellum but progressively affected thalamic, striatal, and cortical regions as well."
      explanation: The Harlequin (AIF-deficient) mouse shows progressive cerebellar neurodegeneration, supporting cerebellar neuronal loss as the substrate of ataxia in AIF-related disease.
  - target: Abnormal Pyramidal Sign
    description: >
      Corticospinal (upper motor neuron) involvement from central neuronal loss
      produces the pyramidal signs reported in part of the AIFM1/CMTX4 spectrum.
  - target: Tremor
    description: >
      Central movement-network (basal-ganglia/striatal) neuronal vulnerability
      contributes to the tremor reported in a subset of AIFM1/CMTX4 patients.
    evidence:
    - reference: PMID:17805014
      reference_title: "Apoptosis-inducing factor deficiency induces early mitochondrial degeneration in brain followed by progressive multifocal neuropathology."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "Neurodegeneration was not restricted to the cerebellum but progressively affected thalamic, striatal, and cortical regions as well."
      explanation: The Harlequin (AIF-deficient) mouse shows progressive striatal (basal-ganglia) neurodegeneration, consistent with the central movement-network vulnerability proposed for the tremor.
  - target: Color Vision Deficiency
    description: >
      Central visual-pathway neuronal vulnerability is the proposed basis of the
      rare colour-vision deficiency reported in the spectrum.
  evidence:
  - reference: PMID:23217327
    reference_title: "Cowchock syndrome is associated with a mutation in apoptosis-inducing factor."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "results in increased cell death via apoptosis, without affecting the activity of the respiratory chain complexes."
    explanation: The founding CMTX4 mutation increases apoptotic cell death independent of respiratory-chain enzyme activity, establishing the pro-apoptotic arm.
  - reference: PMID:36751702
    reference_title: "AIFM1 variants associated with auditory neuropathy spectrum disorder cause apoptosis due to impaired apoptosis-inducing factor dimerization."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "AIFM1 variants associated with auditory neuropathy spectrum disorder cause apoptosis due to impaired apoptosis-inducing factor dimerization."
    explanation: In AIF-mutant auditory-neuron cell models, AIFM1 variants cause apoptosis via impaired AIF dimerization, mechanistically linking the pro-apoptotic arm to the auditory-neuropathy deafness.

- name: Impaired Mitochondrial OXPHOS Complex Assembly
  biological_scale: MOLECULAR
  description: >
    AIFM1 forms a redox-regulated complex with the mitochondrial intermembrane
    space import and assembly protein MIA40 (CHCHD4), and deficiency of either
    protein impairs assembly of mitochondrial respiratory complex I (and
    complex IV). A neuropathy-associated AIFM1 missense mutation (p.Phe210Leu)
    caused abnormal assembly of mitochondrial complexes I and III, providing a
    mechanistic link between AIFM1 dysfunction and defective oxidative
    phosphorylation in affected peripheral nerve.
  genes:
  - preferred_term: AIFM1
    term:
      id: hgnc:8768
      label: AIFM1
  biological_processes:
  - preferred_term: Mitochondrial respiratory chain complex I assembly
    term:
      id: GO:0032981
      label: mitochondrial respiratory chain complex I assembly
    modifier: ABNORMAL
  - preferred_term: Protein import into mitochondrial intermembrane space
    term:
      id: GO:0045041
      label: protein import into mitochondrial intermembrane space
    modifier: ABNORMAL
  downstream:
  - target: Mitochondrial Dysfunction in Peripheral Neurons
    description: >
      Misassembled OXPHOS complexes reduce the mitochondrial energy supply
      available to metabolically demanding peripheral axons.
  evidence:
  - reference: PMID:28888069
    reference_title: "A novel missense mutation in AIFM1 results in axonal polyneuropathy and misassembly of OXPHOS complexes."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "this Phe210Leu mutation resulted in abnormal assembly of mitochondrial complex I and III, and failed to disrupt AIFM1 binding with mitochondrial intermembrane space import and assembly protein 40 (MIA40) in the patients' cells."
    explanation: Patient fibroblast study showing a CMTX4-associated AIFM1 mutation causes misassembly of OXPHOS complexes I and III.
  - reference: PMID:28888069
    reference_title: "A novel missense mutation in AIFM1 results in axonal polyneuropathy and misassembly of OXPHOS complexes."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "Deficiency of either AIFM1 or MIA40 is known to impair the assembly of mitochondrial complex I and IV."
    explanation: Establishes the AIFM1/MIA40 axis as required for assembly of mitochondrial respiratory complexes.
  - reference: PMID:41957773
    reference_title: "Clinical and molecular characterization of a novel pathogenic AIFM1 E336K mutation connecting mitochondrial dysfunction and neurodegeneration."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "Patient-derived fibroblasts exhibited reduced AIF protein stability despite preserved mRNA expression, impaired growth in OXPHOS-dependent conditions, decreased basal respiration, and altered assembly of mitochondrial respiratory supercomplexes."
    explanation: CMTX4 (E336K) patient fibroblasts show reduced AIF stability, impaired respiration, and altered respiratory supercomplex assembly.
  - reference: PMID:41957773
    reference_title: "Clinical and molecular characterization of a novel pathogenic AIFM1 E336K mutation connecting mitochondrial dysfunction and neurodegeneration."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "These defects were accompanied by reduced CHCHD4 protein levels and mitochondrial content."
    explanation: Links the CMTX4 AIF defect to loss of its import partner CHCHD4 (MIA40) and reduced mitochondrial content.

- name: Mitochondrial Dysfunction in Peripheral Neurons
  biological_scale: CELLULAR
  description: >
    AIFM1 dysfunction produces abnormal mitochondrial morphology and
    accumulation within the axoplasm of peripheral nerve fibres and the
    subsarcolemmal region of muscle, reflecting disturbed mitochondrial
    homeostasis in the long peripheral neurons that are most dependent on
    sustained mitochondrial energy supply and transport.
  cell_types:
  - preferred_term: Motor neuron
    term:
      id: CL:0000100
      label: motor neuron
  - preferred_term: Sensory neuron
    term:
      id: CL:0000101
      label: sensory neuron
  biological_processes:
  - preferred_term: Apoptotic process
    term:
      id: GO:0006915
      label: apoptotic process
    modifier: INCREASED
  downstream:
  - target: Distal Axonal Degeneration
    description: >
      Neuronal mitochondrial dysfunction drives length-dependent dying-back
      degeneration of the longest peripheral axons.
  evidence:
  - reference: PMID:30031633
    reference_title: "A novel AIFM1 mutation in a Chinese family with X-linked Charcot-Marie-Tooth disease type 4."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Pathologies exhibited abnormal mitochondrial morphology and accumulation in axoplasm of nerve fiber and subsarcolemmal area of muscle."
    explanation: Nerve/muscle pathology in a CMTX4 family shows abnormal mitochondrial morphology and axoplasmic accumulation, linking AIFM1 mutation to neuronal mitochondrial dysfunction.
  - reference: PMID:17805014
    reference_title: "Apoptosis-inducing factor deficiency induces early mitochondrial degeneration in brain followed by progressive multifocal neuropathology."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "degenerating mitochondria were observed in most cells in these structures, even in nondegenerating neurons, a finding that indicates mitochondrial injury is a cause rather than an effect of neuronal cell death."
    explanation: Harlequin (AIF-downregulated) mouse model shows mitochondrial injury precedes and causes neuronal death, supporting mitochondrial dysfunction as the primary driver of AIF-related neurodegeneration.

- name: Distal Axonal Degeneration
  biological_scale: CELLULAR
  conforms_to: "peripheral_axonal_degeneration#Distal Axonal Degeneration and Demyelination"
  description: >
    The final common pathway in CMTX4 is length-dependent axonal degeneration
    of peripheral nerves, producing a large-fibre sensorimotor axonal
    neuropathy. The longest axons — those of the distal lower limbs — are
    affected first, yielding the characteristic distal-predominant weakness,
    atrophy, and sensory loss.
  cell_types:
  - preferred_term: Motor neuron
    term:
      id: CL:0000100
      label: motor neuron
  - preferred_term: Sensory neuron
    term:
      id: CL:0000101
      label: sensory neuron
  downstream:
  - target: Peripheral Axonal Neuropathy
  - target: Distal Muscle Weakness
  - target: Distal Sensory Impairment
  - target: Distal Lower Limb Amyotrophy
  - target: Pes Cavus
  - target: Hammertoe
  - target: Areflexia
  evidence:
  - reference: PMID:31523922
    reference_title: "Clinical spectrum of AIFM1-associated disease in an Irish family, from mild neuropathy to severe cerebellar ataxia with colour blindness."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Neurophysiology demonstrated length-dependent large-fibre sensorimotor axonal neuropathy, with particular involvement of superficial radial sensory responses."
    explanation: Neurophysiology in an AIFM1/CMTX4 family confirms a length-dependent large-fibre sensorimotor axonal neuropathy as the core lesion.

discussions:
- discussion_id: mismatch_harlequin_knockdown_vs_human_missense
  kind: HUMAN_MODEL_MISMATCH
  status: OPEN
  prompt: >-
    Does the Harlequin (Hq) mouse — in which AIF is downregulated ~80% — faithfully
    model CMTX4, given that human CMTX4 is caused by hemizygous AIFM1 missense
    variants that destabilize AIF and shift its redox/apoptotic behaviour rather
    than simply reducing AIF expression, and given that the Hq mouse phenotype is
    dominated by central (cerebellar/thalamic/striatal/cortical) and retinal
    neurodegeneration rather than the human peripheral-neuropathy-plus-deafness
    presentation?
  attaches_to:
  - pathophysiology#Mitochondrial Dysfunction in Peripheral Neurons
  - pathophysiology#Impaired Mitochondrial OXPHOS Complex Assembly
  rationale: >-
    The principal in vivo AIF model, the Harlequin mouse (PMID:17805014), is a
    loss-of-expression (knockdown) model producing severe complex I deficiency and
    progressive multifocal CNS neurodegeneration. Human CMTX4, by contrast, is
    caused by missense variants (e.g., p.Glu493Val, p.Glu336Lys) that in the
    classic phenotype do NOT cause overt respiratory-chain failure (PMID:23217327)
    but instead destabilize AIF, weaken the AIF:CHCHD4/MIA40 import interaction, and
    perturb supercomplex assembly (PMID:41957773). Whether a knockdown model that
    removes AIF recapitulates the redox-shift, partial-loss-of-function mechanism of
    the human missense disease — and its peripheral-nerve/auditory-neuron tropism —
    is an open translational question.
  proposed_experiments:
  - experiment_id: exp_aifm1_knockin_peripheral_vs_central
    name: Knock-in mouse / iPSC neuron models of human CMTX4 missense variants
    description: >-
      Generate knock-in mice and/or patient-derived iPSC motor and sensory neurons
      carrying specific human CMTX4 missense alleles (e.g., p.Glu493Val,
      p.Glu336Lys) to model the redox-shift mechanism rather than AIF deficiency,
      and directly compare peripheral-nerve versus central/retinal vulnerability
      against the Harlequin knockdown phenotype.
  notes: >-
    Seeded from the OpenScientist deep-research report (2026-07-31), which flagged
    that the dominant animal model is a knockdown emphasizing central/retinal
    phenotypes and does not knock in the human CMTX4 missense alleles.

phenotypes:
- name: Peripheral Axonal Neuropathy
  category: Neurological
  frequency: OBLIGATE
  description: >
    A length-dependent, large-fibre sensorimotor axonal peripheral neuropathy
    is the defining and constant feature of CMTX4, with motor and sensory
    involvement and preserved or near-normal conduction velocities typical of
    an axonopathy.
  phenotype_term:
    preferred_term: Peripheral axonal neuropathy
    term:
      id: HP:0003477
      label: Peripheral axonal neuropathy
    clinical_course: PROGRESSIVE
    onset:
      onset_category: CHILDHOOD
      notes: >
        Classic onset is neonatal to early childhood; across the broader AIFM1
        spectrum reported age of onset ranges from ~18 months to ~39 years.
  evidence:
  - reference: PMID:23217327
    reference_title: "Cowchock syndrome is associated with a mutation in apoptosis-inducing factor."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Cowchock syndrome (CMTX4) is a slowly progressive X-linked recessive disorder with axonal neuropathy, deafness, and cognitive impairment."
    explanation: Defines the CMTX4 core phenotype as a slowly progressive axonal neuropathy.

- name: Distal Muscle Weakness
  category: Musculoskeletal
  frequency: VERY_FREQUENT
  description: >
    Slowly progressive distal limb weakness, predominantly affecting the
    peroneal muscles of the lower legs, producing foot drop and difficulty
    with dorsiflexion.
  phenotype_term:
    preferred_term: Distal muscle weakness
    term:
      id: HP:0002460
      label: Distal muscle weakness
    clinical_course: PROGRESSIVE
  evidence:
  - reference: PMID:30031633
    reference_title: "A novel AIFM1 mutation in a Chinese family with X-linked Charcot-Marie-Tooth disease type 4."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "we report a novel missense variant of AIFM1 in a X-linked recessive Chinese family with childhood-onset, slowly progressive, isolated axonal motor and sensory neuropathy."
    explanation: Documents childhood-onset slowly progressive motor (and sensory) neuropathy in a CMTX4 family.
  - reference: PMID:8666389
    reference_title: "A locus for axonal motor-sensory neuropathy with deafness and mental retardation maps to Xq24-q26."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The patients were severely affected within the first few years of life with distal weakness, muscle atrophy, sensory loss, areflexia, pes cavus, and hammer toes."
    explanation: All seven affected males of the original Cowchock family had early distal weakness, supporting a VERY_FREQUENT band.

- name: Distal Sensory Impairment
  category: Neurological
  frequency: VERY_FREQUENT
  description: >
    Length-dependent distal sensory loss in a stocking-glove distribution,
    reflecting large-fibre sensory axonal degeneration.
  phenotype_term:
    preferred_term: Distal sensory impairment
    term:
      id: HP:0002936
      label: Distal sensory impairment
  evidence:
  - reference: PMID:31523922
    reference_title: "Clinical spectrum of AIFM1-associated disease in an Irish family, from mild neuropathy to severe cerebellar ataxia with colour blindness."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Neurophysiology demonstrated length-dependent large-fibre sensorimotor axonal neuropathy, with particular involvement of superficial radial sensory responses."
    explanation: Confirms the sensory axonal component of the length-dependent neuropathy in CMTX4.
  - reference: PMID:8666389
    reference_title: "A locus for axonal motor-sensory neuropathy with deafness and mental retardation maps to Xq24-q26."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The patients were severely affected within the first few years of life with distal weakness, muscle atrophy, sensory loss, areflexia, pes cavus, and hammer toes."
    explanation: All seven affected males of the original Cowchock family had sensory loss, supporting a VERY_FREQUENT band.

- name: Sensorineural Hearing Impairment
  category: Neurological
  frequency: FREQUENT
  description: >
    Sensorineural deafness is part of the classic Cowchock triad and is
    variably present across affected individuals and families.
  phenotype_term:
    preferred_term: Sensorineural hearing impairment
    term:
      id: HP:0000407
      label: Sensorineural hearing impairment
  evidence:
  - reference: PMID:23217327
    reference_title: "Cowchock syndrome is associated with a mutation in apoptosis-inducing factor."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Cowchock syndrome (CMTX4) is a slowly progressive X-linked recessive disorder with axonal neuropathy, deafness, and cognitive impairment."
    explanation: Establishes sensorineural deafness as a core component of the CMTX4/Cowchock phenotype.
  - reference: PMID:31523922
    reference_title: "Clinical spectrum of AIFM1-associated disease in an Irish family, from mild neuropathy to severe cerebellar ataxia with colour blindness."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "All developed variably present sensorineural deafness, peripheral neuropathy, cerebellar ataxia, and pyramidal involvement."
    explanation: Confirms variably present sensorineural deafness in an AIFM1/CMTX4 family.
  - reference: PMID:8666389
    reference_title: "A locus for axonal motor-sensory neuropathy with deafness and mental retardation maps to Xq24-q26."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Five of the seven affected males showed associated deafness, and three of these five individuals also presented with mental retardation or social developmental delay."
    explanation: Quantifies deafness (5/7 affected males) in the original Cowchock family, supporting a FREQUENT frequency band.

- name: Cognitive Impairment
  category: Neurological
  frequency: OCCASIONAL
  description: >
    Cognitive impairment / intellectual disability was described in the
    original Cowchock family and is part of the classic triad, but it is
    variable and absent in some AIFM1 families, underscoring phenotypic
    heterogeneity.
  phenotype_term:
    preferred_term: Cognitive impairment
    term:
      id: HP:0100543
      label: Cognitive impairment
  evidence:
  - reference: PMID:23217327
    reference_title: "Cowchock syndrome is associated with a mutation in apoptosis-inducing factor."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Cowchock syndrome (CMTX4) is a slowly progressive X-linked recessive disorder with axonal neuropathy, deafness, and cognitive impairment."
    explanation: Establishes cognitive impairment as part of the original Cowchock triad.
  - reference: PMID:31523922
    reference_title: "Clinical spectrum of AIFM1-associated disease in an Irish family, from mild neuropathy to severe cerebellar ataxia with colour blindness."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "All individuals had normal cognitive assessment."
    explanation: Documents preserved cognition in one large AIFM1 family, supporting the variable/occasional nature of cognitive impairment in the spectrum.

- name: Distal Lower Limb Amyotrophy
  category: Musculoskeletal
  frequency: VERY_FREQUENT
  description: >
    Wasting of the distal lower-limb muscles, with fatty infiltration and
    atrophy prominent in the peroneal compartment on muscle imaging.
  phenotype_term:
    preferred_term: Distal lower limb amyotrophy
    term:
      id: HP:0008944
      label: Distal lower limb amyotrophy
  evidence:
  - reference: PMID:30031633
    reference_title: "A novel AIFM1 mutation in a Chinese family with X-linked Charcot-Marie-Tooth disease type 4."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Calf magnetic resonance imaging revealed fatty infiltration and atrophy severely involving the muscles of peroneal compartment."
    explanation: MRI documents peroneal-predominant muscle atrophy/fatty infiltration in a CMTX4 family.
  - reference: PMID:8666389
    reference_title: "A locus for axonal motor-sensory neuropathy with deafness and mental retardation maps to Xq24-q26."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The patients were severely affected within the first few years of life with distal weakness, muscle atrophy, sensory loss, areflexia, pes cavus, and hammer toes."
    explanation: All seven affected males of the original Cowchock family had muscle atrophy, supporting a VERY_FREQUENT band.

- name: Pes Cavus
  category: Musculoskeletal
  frequency: VERY_FREQUENT
  description: >
    High-arched feet resulting from the intrinsic-extrinsic foot muscle
    imbalance characteristic of length-dependent motor neuropathy.
  phenotype_term:
    preferred_term: Pes cavus
    term:
      id: HP:0001761
      label: Pes cavus
  evidence:
  - reference: PMID:8666389
    reference_title: "A locus for axonal motor-sensory neuropathy with deafness and mental retardation maps to Xq24-q26."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The patients were severely affected within the first few years of life with distal weakness, muscle atrophy, sensory loss, areflexia, pes cavus, and hammer toes."
    explanation: All seven affected males of the original Cowchock family had pes cavus, supporting a VERY_FREQUENT band.

- name: Hammertoe
  category: Musculoskeletal
  frequency: VERY_FREQUENT
  description: >
    Hammer-toe deformity accompanies the pes cavus as part of the
    length-dependent motor neuropathy foot phenotype, and is named as a
    defining feature in the Orphanet/MONDO definition of the entity.
  phenotype_term:
    preferred_term: Hammertoe
    term:
      id: HP:0001765
      label: Hammertoe
  evidence:
  - reference: PMID:8666389
    reference_title: "A locus for axonal motor-sensory neuropathy with deafness and mental retardation maps to Xq24-q26."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The patients were severely affected within the first few years of life with distal weakness, muscle atrophy, sensory loss, areflexia, pes cavus, and hammer toes."
    explanation: All seven affected males of the original Cowchock family had hammer toes, supporting a VERY_FREQUENT band.

- name: Areflexia
  category: Neurological
  frequency: VERY_FREQUENT
  description: >
    Absent or reduced deep tendon reflexes from loss of the sensory afferent
    arc, typical of a peripheral axonal neuropathy.
  phenotype_term:
    preferred_term: Areflexia
    term:
      id: HP:0001284
      label: Areflexia
  evidence:
  - reference: PMID:8666389
    reference_title: "A locus for axonal motor-sensory neuropathy with deafness and mental retardation maps to Xq24-q26."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The patients were severely affected within the first few years of life with distal weakness, muscle atrophy, sensory loss, areflexia, pes cavus, and hammer toes."
    explanation: All seven affected males of the original Cowchock family had areflexia, supporting a VERY_FREQUENT band.

- name: Cerebellar Ataxia
  category: Neurological
  frequency: OCCASIONAL
  description: >
    A cerebellar-ataxia-predominant presentation with cerebellar atrophy has
    been described in the AIFM1/CMTX4 spectrum, and the disorder is
    designated "CMTX4 with or without cerebellar ataxia." Ataxia and pyramidal
    signs occur in some families in addition to the peripheral neuropathy.
  phenotype_term:
    preferred_term: Progressive cerebellar ataxia
    term:
      id: HP:0002073
      label: Progressive cerebellar ataxia
  evidence:
  - reference: PMID:31523922
    reference_title: "Clinical spectrum of AIFM1-associated disease in an Irish family, from mild neuropathy to severe cerebellar ataxia with colour blindness."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "All developed variably present sensorineural deafness, peripheral neuropathy, cerebellar ataxia, and pyramidal involvement."
    explanation: Documents cerebellar ataxia and pyramidal involvement within the AIFM1/CMTX4 clinical spectrum.

- name: Abnormal Pyramidal Sign
  category: Neurological
  frequency: OCCASIONAL
  description: >
    Pyramidal (upper motor neuron) signs accompany the peripheral neuropathy in
    part of the AIFM1/CMTX4 spectrum, reflecting central corticospinal
    involvement.
  notes: >-
    Frequency banded consistently with cerebellar ataxia (OCCASIONAL), since
    both derive from the same variably-present PMID:31523922 clinical clause.
  phenotype_term:
    preferred_term: Abnormal pyramidal sign
    term:
      id: HP:0007256
      label: Abnormal pyramidal sign
  evidence:
  - reference: PMID:31523922
    reference_title: "Clinical spectrum of AIFM1-associated disease in an Irish family, from mild neuropathy to severe cerebellar ataxia with colour blindness."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "All developed variably present sensorineural deafness, peripheral neuropathy, cerebellar ataxia, and pyramidal involvement."
    explanation: Documents pyramidal involvement in an AIFM1/CMTX4 family.

- name: Tremor
  category: Neurological
  frequency: OCCASIONAL
  description: >
    A progressive movement-disorder component with disabling tremor occurs in a
    subset of CMTX4 patients and can be poorly responsive to medication, forming
    part of the broader AIFM1 movement-disorder/cerebellar spectrum.
  phenotype_term:
    preferred_term: Tremor
    term:
      id: HP:0001337
      label: Tremor
  evidence:
  - reference: PMID:36907087
    reference_title: "Deep Brain Stimulation for the Management of AIFM1-Related Disabling Tremor: A Case Series."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Both individuals had a progressive complex movement disorder phenotype, including disabling tremor poorly responsive to medications."
    explanation: Documents disabling, medication-refractory tremor in two brothers with a Cowchock-syndrome AIFM1 variant.

- name: Color Vision Deficiency
  category: Neurological
  frequency: VERY_RARE
  description: >
    Colour-vision deficiency was reported in a subset of one large AIFM1/CMTX4
    family, representing a rare extension of the phenotypic spectrum.
  phenotype_term:
    preferred_term: Color vision defect
    term:
      id: HP:0000551
      label: Color vision defect
  evidence:
  - reference: PMID:31523922
    reference_title: "Clinical spectrum of AIFM1-associated disease in an Irish family, from mild neuropathy to severe cerebellar ataxia with colour blindness."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In addition, three had colour vision deficiency."
    explanation: Documents colour-vision deficiency in three affected males of the Irish AIFM1/CMTX4 family.

genetic:
- name: AIFM1
  gene_term:
    preferred_term: AIFM1
    term:
      id: hgnc:8768
      label: AIFM1
  association: Causative
  features: >
    Hemizygous missense variants in AIFM1 (Xq26.1) cause CMTX4. Reported
    pathogenic variants include the founding p.Glu493Val, p.Phe210Leu,
    p.Met171Ile, p.Leu311Val, p.Glu336Lys, and p.His457Tyr. AIFM1 encodes an
    FAD-dependent NADH oxidoreductase imported into the mitochondrial
    intermembrane space; most pathogenic variants cluster within its FAD- and
    NADH-binding domains, consistent with a redox-balance mechanism. Penetrance
    is high in hemizygous males, while expressivity is highly variable — even
    within a single family and for the same variant — spanning mild neuropathy
    to a severe multisystem cerebellar/encephalopathic presentation.
  evidence:
  - reference: PMID:23217327
    reference_title: "Cowchock syndrome is associated with a mutation in apoptosis-inducing factor."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The change is at a highly conserved residue and cosegregated with the phenotype in the family."
    explanation: Cosegregation of the AIFM1 p.Glu493Val variant with the CMTX4 phenotype supports causality.
  - reference: PMID:37173762
    reference_title: "Whole-exome sequencing detected a novel AIFM1 variant in a Han-Chinese family with Cowchock syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The apoptosis-inducing factor mitochondria associated-1 (AIFM1) is the main pathogenic gene of the X-linked recessive Charcot-Marie-Tooth disease-4 with or without cerebellar ataxia (CMTX4), also known as Cowchock syndrome."
    explanation: Confirms AIFM1 as the causative gene of CMTX4/Cowchock syndrome.
  - reference: PMID:41957773
    reference_title: "Clinical and molecular characterization of a novel pathogenic AIFM1 E336K mutation connecting mitochondrial dysfunction and neurodegeneration."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "we identified and comprehensively characterized a novel hemizygousAIFM1mutation c.1006G > A (E336K) in a male patient presenting with a progressive hereditary axonal sensorimotor polyneuropathy with childhood onset, inherited in an X-linked recessive pattern, associated with sensorineural hearing loss and without cognitive impairment. The clinical phenotype was consistent with Charcot-Marie-Tooth disease type 4 (CMTX4)."
    explanation: Adds a functionally characterized AIFM1 CMTX4 variant (E336K) with the classic axonal neuropathy plus deafness phenotype.

inheritance:
- name: X-linked Recessive
  inheritance_term:
    preferred_term: X-linked recessive inheritance
    term:
      id: HP:0001419
      label: X-linked recessive inheritance
  description: >
    CMTX4 follows X-linked recessive inheritance: affected individuals are
    hemizygous males carrying an AIFM1 variant, and obligate female carriers
    are typically clinically unaffected. Rarely, across the broader AIFM1
    allelic spectrum, a heterozygous female can manifest disease when X-linked
    inactivation is extremely skewed.
  evidence:
  - reference: PMID:8666389
    reference_title: "A locus for axonal motor-sensory neuropathy with deafness and mental retardation maps to Xq24-q26."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Heterozygous females were asymptomatic."
    explanation: Original Cowchock-family linkage study confirms asymptomatic heterozygous female carriers, consistent with X-linked recessive inheritance.
  - reference: PMID:31523922
    reference_title: "Clinical spectrum of AIFM1-associated disease in an Irish family, from mild neuropathy to severe cerebellar ataxia with colour blindness."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Four obligate female carriers were assessed clinically, two of them neurophysiologically; all were unaffected."
    explanation: Confirms X-linked recessive inheritance with asymptomatic obligate female carriers.
  - reference: PMID:42329587
    reference_title: "Cardiomyopathy and mitochondrial encephalomyopathy in a female child associated with a heterozygous X-linked AIFM1 variant."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "A heterozygous AIFM1 variant can result in disease manifestation in females."
    explanation: Documents that, in the broader AIFM1 spectrum, a heterozygous female can manifest disease (via skewed X-inactivation) — a genetic-counseling caveat; the reported female had a severe (encephalomyopathy/cardiomyopathy) phenotype rather than classic CMTX4.

diagnosis:
- name: Nerve Conduction Studies and Electromyography
  description: >
    Neurophysiology demonstrates a length-dependent, large-fibre sensorimotor
    axonal neuropathy with reduced sensory and motor amplitudes and relatively
    preserved conduction velocities (axonal pattern). Particular involvement of
    the superficial radial sensory response has been proposed as a phenotypic
    marker.
  evidence:
  - reference: PMID:31523922
    reference_title: "Clinical spectrum of AIFM1-associated disease in an Irish family, from mild neuropathy to severe cerebellar ataxia with colour blindness."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Superficial radial nerve was particularly affected neurophysiologically, which could represent a phenotypic marker towards this specific genetic diagnosis."
    explanation: Describes the axonal neurophysiology and a candidate phenotypic marker useful for diagnosis.

- name: Molecular Genetic Testing
  description: >
    Diagnosis is confirmed by identification of a hemizygous pathogenic AIFM1
    variant, typically via exome or whole-genome sequencing in a male with
    X-linked recessive axonal neuropathy with or without deafness, cognitive
    impairment, or cerebellar ataxia.
  evidence:
  - reference: PMID:23217327
    reference_title: "Cowchock syndrome is associated with a mutation in apoptosis-inducing factor."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Exome sequencing of an affected individual from the originally described family identified a missense change c.1478A>T (p.Glu493Val) in AIFM1, the gene encoding apoptosis-inducing factor (AIF) mitochondrion-associated 1."
    explanation: Establishes AIFM1 sequencing as the molecular diagnostic approach for CMTX4.

- name: Audiologic Evaluation
  description: >
    Audiometry with auditory brainstem response (ABR) testing characterises the
    hearing loss as an auditory neuropathy pattern — abnormal auditory-nerve /
    inner-hair-cell function with preserved outer hair cell (otoacoustic
    emission) responses — which distinguishes the neural deafness of the AIFM1
    spectrum from ordinary cochlear loss and guides rehabilitation choice.
  evidence:
  - reference: PMID:36751702
    reference_title: "AIFM1 variants associated with auditory neuropathy spectrum disorder cause apoptosis due to impaired apoptosis-inducing factor dimerization."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Auditory neuropathy spectrum disorder (ANSD) represents a variety of sensorineural deafness conditions characterized by abnormal inner hair cells and/or auditory nerve function, but with the preservation of outer hair cell function."
    explanation: Defines the auditory-neuropathy audiologic pattern (abnormal auditory nerve with preserved outer hair cells) that characterises AIFM1-associated deafness.

- name: Muscle MRI
  description: >
    Calf muscle MRI shows fatty infiltration and atrophy with a
    peroneal-compartment predominance, supporting the length-dependent motor phenotype.
  evidence:
  - reference: PMID:30031633
    reference_title: "A novel AIFM1 mutation in a Chinese family with X-linked Charcot-Marie-Tooth disease type 4."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Calf magnetic resonance imaging revealed fatty infiltration and atrophy severely involving the muscles of peroneal compartment."
    explanation: Calf MRI documents the peroneal-predominant fatty infiltration/atrophy pattern useful in the diagnostic workup.

histopathology:
- name: Sural Nerve and Muscle Mitochondrial Pathology
  description: >
    Nerve and muscle biopsy in CMTX4 shows abnormal mitochondrial morphology
    with accumulation of mitochondria in the axoplasm of nerve fibres and in the
    subsarcolemmal region of muscle, the tissue correlate of the mitochondrial
    dysfunction driven by AIFM1 mutation.
  diagnostic: true
  evidence:
  - reference: PMID:30031633
    reference_title: "A novel AIFM1 mutation in a Chinese family with X-linked Charcot-Marie-Tooth disease type 4."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Pathologies exhibited abnormal mitochondrial morphology and accumulation in axoplasm of nerve fiber and subsarcolemmal area of muscle."
    explanation: Nerve/muscle histopathology shows abnormal mitochondrial morphology and axoplasmic/subsarcolemmal mitochondrial accumulation in CMTX4.

prevalence:
- population: Worldwide
  measure_type: CASES_IN_LITERATURE
  prevalence_class: NOT_YET_DOCUMENTED
  notes: >
    CMTX4 is an ultra-rare AIFM1 subtype of Charcot-Marie-Tooth disease
    described in only a small number of families worldwide (the original US
    family plus Irish, Chinese, Spanish, and other kindreds); no formal
    prevalence or incidence figure has been established.

progression:
- phase: Overall course
  duration: Lifelong
  notes: >
    Slowly progressive, chronic, lifelong course with onset from the neonatal
    period to early childhood in the classic form (reported spectrum ~18 months
    to ~39 years); no relapsing-remitting pattern or spontaneous remission.
  evidence:
  - reference: PMID:23217327
    reference_title: "Cowchock syndrome is associated with a mutation in apoptosis-inducing factor."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Cowchock syndrome (CMTX4) is a slowly progressive X-linked recessive disorder with axonal neuropathy, deafness, and cognitive impairment."
    explanation: Establishes the slowly progressive course of CMTX4.

treatments:
- name: Physical Therapy and Rehabilitation
  description: >
    Supportive physiotherapy to maintain strength, flexibility, and gait, as
    for other forms of Charcot-Marie-Tooth disease; no disease-modifying
    therapy is currently available for CMTX4.
  therapeutic_modality: BEHAVIORAL
  treatment_term:
    preferred_term: physical therapy
    term:
      id: NCIT:C15302
      label: Physical Therapy

- name: Orthotic Devices
  description: >
    Ankle-foot orthoses to compensate for foot drop and improve gait
    stability, with orthopedic footwear for foot deformities.
  therapeutic_modality: DEVICE
  treatment_term:
    preferred_term: orthotic supportive care
    term:
      id: NCIT:C15747
      label: Supportive Care

- name: Hearing Rehabilitation
  description: >
    Management of sensorineural deafness with hearing aids, addressing the
    auditory component of the Cowchock phenotype. Because the hearing loss in
    the AIFM1 spectrum is a neural (auditory neuropathy spectrum disorder /
    DFNX5) phenomenon rather than pure cochlear loss, device selection is guided
    by audiologic (ABR) characterisation.
  therapeutic_modality: DEVICE
  treatment_term:
    preferred_term: supportive care
    term:
      id: NCIT:C15747
      label: Supportive Care
  evidence:
  - reference: PMID:36751702
    reference_title: "AIFM1 variants associated with auditory neuropathy spectrum disorder cause apoptosis due to impaired apoptosis-inducing factor dimerization."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Auditory neuropathy spectrum disorder (ANSD) represents a variety of sensorineural deafness conditions characterized by abnormal inner hair cells and/or auditory nerve function, but with the preservation of outer hair cell function."
    explanation: Establishes that AIFM1-associated deafness is an auditory neuropathy (neural) phenotype, informing hearing-rehabilitation choice.

- name: Cochlear Implantation
  description: >
    Cochlear implantation may be considered for the auditory-neuropathy hearing
    loss of the AIFM1 spectrum when conventional amplification is inadequate,
    stimulating the cochlear nerve directly.
  therapeutic_modality: DEVICE
  treatment_term:
    preferred_term: cochlear implantation
    term:
      id: NCIT:C15329
      label: Surgical Procedure
  target_phenotypes:
  - preferred_term: Sensorineural hearing impairment
    term:
      id: HP:0000407
      label: Sensorineural hearing impairment
  evidence:
  - reference: PMID:36751702
    reference_title: "AIFM1 variants associated with auditory neuropathy spectrum disorder cause apoptosis due to impaired apoptosis-inducing factor dimerization."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Auditory neuropathy spectrum disorder (ANSD) represents a variety of sensorineural deafness conditions characterized by abnormal inner hair cells and/or auditory nerve function, but with the preservation of outer hair cell function."
    explanation: The neural (auditory-neuropathy) character of AIFM1 deafness is the rationale for considering cochlear implantation over amplification in selected patients.

- name: Orthopedic Surgery for Foot Deformity
  description: >
    Corrective orthopedic surgery (e.g., tendon transfers, osteotomies) for
    severe pes cavus and hammer-toe deformities when conservative measures fail
    to maintain functional ambulation.
  therapeutic_modality: SURGERY
  treatment_term:
    preferred_term: orthopedic surgical procedure
    term:
      id: NCIT:C16186
      label: Orthopedic Surgical Procedure
  target_phenotypes:
  - preferred_term: Pes cavus
    term:
      id: HP:0001761
      label: Pes cavus
  - preferred_term: Hammertoe
    term:
      id: HP:0001765
      label: Hammertoe

- name: Deep Brain Stimulation for AIFM1-Related Tremor
  description: >
    Deep brain stimulation of the ventral intermediate thalamic nucleus has
    been used to manage disabling, medication-refractory tremor in AIFM1-related
    (Cowchock-syndrome) disease, improving contralateral tremor and quality of
    life.
  therapeutic_modality: DEVICE
  treatment_term:
    preferred_term: deep brain stimulation
    term:
      id: NCIT:C21024
      label: Deep Brain Stimulation
  target_phenotypes:
  - preferred_term: Tremor
    term:
      id: HP:0001337
      label: Tremor
  evidence:
  - reference: PMID:36907087
    reference_title: "Deep Brain Stimulation for the Management of AIFM1-Related Disabling Tremor: A Case Series."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Deep brain stimulation (DBS) of the ventral intermediate thalamic nucleus ameliorated contralateral tremor and improved their quality of life; this suggests the beneficial role for DBS in treatment-resistant tremor within AIFM1-related disorders."
    explanation: Case series supporting DBS for treatment-resistant tremor in AIFM1-related/Cowchock-syndrome disease.

- name: Genetic Counseling
  description: >
    Genetic counseling for X-linked recessive inheritance, including carrier
    testing of at-risk female relatives and reproductive counseling.
  treatment_term:
    preferred_term: Genetic Counseling
    term:
      id: NCIT:C15240
      label: Genetic Counseling
  evidence:
  - reference: PMID:37173762
    reference_title: "Whole-exome sequencing detected a novel AIFM1 variant in a Han-Chinese family with Cowchock syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The results of our study may also be useful for genetic counseling, embryo screening of in vitro fertilization embryos, and prenatal genetic diagnosis."
    explanation: Supports genetic counseling and reproductive options for families with AIFM1/CMTX4.
  - reference: PMID:20301532
    reference_title: "Charcot-Marie-Tooth Hereditary Neuropathy Overview."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Inform genetic counseling of family members of an individual with CMT hereditary neuropathy."
    explanation: The GeneReviews CMT overview (baseline reference; no CMTX4-specific GeneReviews exists) includes genetic counseling of family members as standard CMT management.

references:
- reference: PMID:20301532
  title: "Charcot-Marie-Tooth Hereditary Neuropathy Overview."
  tags:
  - GeneReviews
- reference: PMID:3856385
  title: "X-linked motor-sensory neuropathy type-II with deafness and mental retardation: a new disorder."
- reference: PMID:23217327
  title: "Cowchock syndrome is associated with a mutation in apoptosis-inducing factor."

datasets: []
📚

References & Deep Research

References

3
PMID:20301532
Charcot-Marie-Tooth Hereditary Neuropathy Overview.
No top-level findings curated for this source.
PMID:3856385
X-linked motor-sensory neuropathy type-II with deafness and mental retardation: a new disorder.
No top-level findings curated for this source.
PMID:23217327
Cowchock syndrome is associated with a mutation in apoptosis-inducing factor.
No top-level findings curated for this source.

Deep Research

1
OpenScientist ▸
Key Findings
openscientist-autonomous 28 citations 2026-07-31T17:50:31.447597

Key Findings

Finding 1 — CMTX4/Cowchock syndrome is caused by hemizygous AIFM1 missense variants at Xq26.1

Exome sequencing of an affected individual from the originally described Cowchock family identified a missense change c.1478A>T (p.Glu493Val) in AIFM1, the gene encoding apoptosis-inducing factor (AIF), which cosegregated with the phenotype (PMID: 23217327). This built upon earlier linkage work that had mapped the locus to Xq24–q26: "DXS425 (Xq24) and HPRT (Xq26.1) are flanking markers and that the disease gene is closely linked to the markers DXS1122, DXS994, DXS737, DXS1206, and DXS1047" (PMID: 8666389).

AIFM1 (HGNC:8768, cytoband Xq26.1, NCBI Gene 9131) encodes a FAD-dependent NADH oxidase that is imported into mitochondria. The disease phenotype carries OMIM 310490 (Cowchock/CMTX4), with the gene at OMIM 300169. Additional pathogenic missense variants have since been reported across multiple families worldwide, confirming AIFM1 as the single causal gene for this subtype.

Ontology anchors: MONDO — Charcot-Marie-Tooth disease X-linked recessive 4 / Cowchock syndrome; gene AIFM1 (HGNC:8768).

Finding 2 — Core phenotype: axonal sensorimotor neuropathy + sensorineural deafness + cognitive impairment, with variable cerebellar ataxia

The original 1985 description documented severe distal weakness, muscle atrophy, sensory loss, areflexia, pes cavus, and hammer toes from infancy, with 5 of 7 affected males exhibiting deafness and 3 of 5 showing intellectual disability (PMID: 3856385; PMID: 8666389). The authors emphasized "the observation that males are severely affected from infancy, and the frequent association of deafness and/or mental retardation with the neuromuscular disorder."

The clinical spectrum was substantially expanded by an Irish family (7 affected males; onset ranging from 18 months to 39 years; SARA ataxia scores 2–23/40; CMTNS2 scores 7–13/36), in which "All developed variably present sensorineural deafness, peripheral neuropathy, cerebellar ataxia, and pyramidal involvement. In addition, three had colour vision deficiency" (PMID: 31523922). Nerve conduction studies show a length-dependent large-fibre axonal sensorimotor neuropathy with markedly abnormal sensory responses.

Suggested HPO terms: HP:0003477 (Peripheral sensorimotor neuropathy), HP:0000407 (Sensorineural hearing impairment), HP:0001272/HP:0001251 (Cerebellar atrophy/Ataxia), HP:0007256/HP:0001347 (Pyramidal/Hyperreflexia), HP:0001761 (Pes cavus), HP:0001284 (Areflexia), HP:0001256 (Intellectual disability, mild), HP:0000551 (Abnormality of color vision), HP:0001337 (Tremor).

Finding 3 — Mechanism: AIFM1 variants impair AIF redox/import functions rather than causing overt OXPHOS failure

The p.Glu493Val CMTX4 mutation "alters the redox properties of the AIF protein and results in increased cell death via apoptosis, without affecting the activity of the respiratory chain complexes" (PMID: 23217327). This is a critical distinction: unlike the severe infantile encephalomyopathies at the other end of the AIFM1 spectrum, CMTX4 is driven by a subtler redox/apoptotic imbalance rather than a wholesale collapse of oxidative phosphorylation.

AIF supports respiration indirectly by promoting the import of MIA40 (CHCHD4 in humans) and the assembly of complex I; it functions as a "redox-controlled gear box to switch between mitochondrial biogenesis and cell death" (PMID: 32769219). Supporting the neurodegenerative relevance, AIF-deficient Harlequin mice show a 40–50% reduction in complex I with progressive multifocal neurodegeneration prominent in the cerebellum (PMID: 17805014; PMID: 19280713).

Suggested GO terms: GO:0006915 (apoptotic process), GO:0032981 (mitochondrial respiratory chain complex I assembly), GO:0045333 (cellular respiration), GO:0016651 (oxidoreductase activity), GO:0006626 (protein targeting to mitochondrion).

Finding 4 — AIF is a FAD/NADH oxidoreductase whose redox-linked dimerization couples metabolism to caspase-independent apoptosis

AIF is a FAD-containing, NADH-dependent oxidoreductase resident in the mitochondrial intermembrane space. Upon apoptotic insult it is proteolyzed and translocates to the nucleus to trigger caspase-independent chromatin condensation and DNA degradation. Its redox activity "is essential for optimal oxidative phosphorylation. Additionally, the protein is proposed to regulate the respiratory chain indirectly, through assembly and/or stabilization of complexes I and III" (PMID: 20868295).

X-ray crystallography reveals the structural basis of the switch: NADH reduction drives formation of a tight FADH2–NAD charge-transfer complex, and "redox changes in the active site are transmitted to the surface, promoting AIF dimerization and restricting access to a primary nuclear localization signal through which the apoptogenic form is transported to the nucleus" (PMID: 19447115). Pathological-equivalent mutations in the adenylate-binding site (e.g., murine G307E, equivalent to human G308E) "decrease the affinity and association rate of NAD(+)/H, which, in turn, perturbs CT complex formation and protein dimerization" (PMID: 26535916). These structural insights explain how single missense substitutions perturb AIF's dual life/death functions.

Suggested CHEBI terms: CHEBI:16238 (FAD), CHEBI:16908 (NADH), CHEBI:15846 (NAD+).

Finding 5 — Mechanism refined: CMTX4 variants destabilize AIF, deplete CHCHD4, and impair respiratory supercomplex assembly

A hemizygous AIFM1 c.1006G>A (p.Glu336Lys) variant in a male with childhood-onset progressive axonal sensorimotor polyneuropathy and sensorineural hearing loss — a canonical CMTX4 phenotype — provided direct mechanistic evidence. Patient-derived fibroblasts "exhibited reduced AIF protein stability despite preserved mRNA expression, impaired growth in OXPHOS-dependent conditions, decreased basal respiration, and altered assembly of mitochondrial respiratory supercomplexes. These defects were accompanied by reduced CHCHD4 protein levels and mitochondrial content" (PMID: 41957773).

Biophysical characterization of purified protein showed the "E336K protein exhibited compromised FAD retention, decreased thermal stability, impaired NADH affinity, destabilization of the charge-transfer complex crucial for sustaining the AIF:CHCHD4 interaction" with a shift toward NADPH and remodeling of the NADH-binding cleft (PMID: 41957773). This unifies the CMTX4 pathomechanism: protein destabilization → weakened AIF:CHCHD4/MIA40 import machinery → impaired complex I/supercomplex assembly → mitochondrial dysfunction and neurodegeneration, consistent with the redox mechanism first shown for p.Glu493Val.

Finding 6 — The Harlequin (Hq) mouse is the principal AIF-deficiency model, recapitulating cerebellar/sensory neurodegeneration and complex I loss

The Harlequin (Hq) mouse carries a proviral insertion that downregulates Aif by ~80% and develops severe mitochondrial complex I deficiency (40–50% reduction), degenerating mitochondria, and progressive multifocal neurodegeneration. Notably, "Neurodegeneration was not restricted to the cerebellum but progressively affected thalamic, striatal, and cortical regions as well" (PMID: 17805014), tracking along somatosensory-motor pathways relevant to the human disease.

Hq mice also display retinal photoreceptor degeneration that is rescued by the redox compound methylene blue (PMID: 30300862), and heightened susceptibility to complex I neurotoxins (MPTP) that is reversible by the antioxidant tempol (PMID: 20695011), illustrating a gene–environment interaction and candidate redox-protective strategies. Cross-breeding with P301L tau mice aggravates tau pathology and neurodegeneration, linking AIF deficiency to broader neurodegenerative processes (PMID: 19942317). Mouse ortholog: Aifm1 (NCBI Gene 26926); human AIFM1 (NCBI Gene 9131).

Finding 7 — CMTX4 hearing loss reflects auditory neuropathy; AIFM1 causes auditory neuropathy spectrum disorder (DFNX5)

The sensorineural deafness in CMTX4 is best characterized as auditory neuropathy. Auditory neuropathy spectrum disorder (ANSD) "represents a variety of sensorineural deafness conditions characterized by abnormal inner hair cells and/or auditory neurons" with preserved outer hair cell function, accounting for up to ~15% of hearing-impaired patients; AIFM1 variants have been identified in ANSD families and sporadic cases (PMID: 36751702). AIFM1-associated X-linked deafness is catalogued as DFNX5/AUNX1 (OMIM 300614). This explains why the hearing loss in CMTX4 is a neural (retrocochlear) phenomenon consistent with the broader axonopathy, and it has direct implications for choosing cochlear implantation over conventional amplification in some patients.

Suggested UBERON/CL terms: UBERON:0001844 (cochlea), UBERON:0002227 (spiral ganglion), CL:0000601 (cochlear inner hair cell), CL:0000103 (bipolar neuron/auditory neuron).

Finding 8 — CMTX4 is an ultra-rare X-linked recessive subtype within CMT

CMT overall "are the most frequent genetically-determined peripheral neuropathies, with a global prevalence between 4.7 and 36/100,000" (PMID: 20929675); e.g., population-based prevalence "in Cyprus… is estimated to be 16 per 100,000" (PMID: 20571287). The most common subtypes are CMT1A (PMP22 duplication) and CMTX1 (GJB1/Cx32). CMTX4/AIFM1 is not among the frequent genotypes and has been described only in a small number of families worldwide (the original US family, plus Irish, Han-Chinese, Italian, and other kindreds; PMID: 3856385, PMID: 31523922, PMID: 37173762, PMID: 30031633, PMID: 26173962).

No formal prevalence/incidence figure exists for CMTX4 specifically; Orphanet lists it as a very rare disorder. Inheritance is X-linked recessive, with affected hemizygous males and typically asymptomatic obligate carrier females.

Finding 9 — Diagnosis relies on nerve conduction studies (axonal pattern) plus molecular confirmation of AIFM1

CMTX4 is an axonal (CMT2-type) neuropathy: nerve conduction shows length-dependent large-fibre sensorimotor axonal neuropathy with normal-to-mildly reduced motor conduction velocity and markedly abnormal sensory responses (PMID: 8666389; PMID: 31523922). Calf MRI reveals fatty infiltration/atrophy predominantly of the peroneal compartment. Nerve and muscle pathology in one Chinese family showed "abnormal mitochondrial morphology and accumulation in axoplasm of nerve fiber and subsarcolemmal area of muscle. A hemizygous variant (c.513G>A, p.Met171Ile)… was classified as likely pathogenic according to the standards and guidelines of the American College of Medical Genetics and Genomics" (PMID: 30031633).

Molecular diagnosis is by NGS/exome or gene-panel testing. A comprehensive next-generation-sequencing approach is the practical diagnostic route for axonal CMT, where "almost half of axonal CMT families had at least a possible diagnosis with the comprehensive NGS panel" (PMID: 32506583). Whole-exome/whole-genome sequencing identified variants across multiple CMTX4 families (PMID: 23217327; PMID: 37173762; PMID: 31523922).

Finding 10 — No disease-specific therapy; management is supportive/rehabilitative, with DBS effective for AIFM1-related tremor

"At present, there is no drug therapy for Charcot-Marie-Tooth disease, and rehabilitation therapy and surgical procedures for skeletal deformities are the only available treatments" (PMID: 19539237). Care is delivered in a multidisciplinary setting involving neurologists, physiatrists, orthopedic surgeons, therapists, and orthotists (PMID: 18334132). Experimental CMT approaches (ascorbic acid, curcumin, progesterone antagonists) target demyelinating CMT1A, not AIFM1 axonal disease, and are not applicable here.

For AIFM1-related disabling tremor, "Deep brain stimulation (DBS) of the ventral intermediate thalamic nucleus ameliorated contralateral tremor and improved their quality of life; this suggests the beneficial role for DBS in treatment-resistant tremor within AIFM1-related disorders" (PMID: 36907087). Hearing aids or cochlear implants address the sensorineural/auditory-neuropathy component.

Suggested NCIT terms: NCIT:C15275 (Physical Therapy), NCIT:C15329 (Rehabilitation Therapy), Orthotic Device, NCIT:C38013 (Deep Brain Stimulation), Cochlear Implant.

Finding 11 — AIFM1 disease is an allelic spectrum; carrier females can manifest via skewed X-inactivation

AIFM1 variants cause a wide allelic spectrum spanning from the milder CMTX4/Cowchock phenotype to severe COXPD6 mitochondrial encephalomyopathy, DFNX5 auditory neuropathy, spondyloepimetaphyseal dysplasia with neurodegeneration (PMID: 27102849), infantile motor-neuron/anterior-horn disease (PMID: 26173962; PMID: 39601015), neonatal seizures (PMID: 37644805), and cardiomyopathy. As one review states, "Pathogenic variants in AIFM1 have been associated with a wide spectrum of disorders, spanning from CMT4X to mitochondrial encephalopathy" (PMID: 37644805).

Although X-linked recessive, a heterozygous female can manifest disease: "Genetic testing identified a heterozygous AIFM1 variant, c.506C>T (p.Pro169Leu), with extremely skewed X-inactivation (98:2) in a female" who developed infantile mitochondrial encephalomyopathy and cardiomyopathy (PMID: 42329587). Intrafamilial variability is marked even for the same variant (PMID: 39601015; PMID: 31523922).

Finding 12 — Genetic counseling and prevention framework (X-linked recessive)

CMTX4 follows X-linked recessive transmission: carrier mothers pass the AIFM1 variant to 50% of offspring; sons inheriting it are affected, daughters are carriers; affected males transmit to all daughters (obligate carriers) and to no sons. Identification of the familial variant enables downstream prevention — "The results of our study may also be useful for genetic counseling, embryo screening of in vitro fertilization embryos, and prenatal genetic diagnosis" (PMID: 37173762). Counseling must account for manifesting female carriers with skewed X-inactivation (PMID: 42329587). No population-level primary prevention exists; secondary prevention is cascade testing plus early audiologic and neurophysiologic surveillance of at-risk relatives.

Section-by-Section Knowledge Base Content

1. Disease Information

CMTX4 is an X-linked recessive axonal Charcot-Marie-Tooth neuropathy defined by peripheral sensorimotor neuropathy combined with sensorineural (auditory-neuropathy) deafness and, frequently, cognitive impairment and cerebellar/pyramidal features. Identifiers: OMIM 310490 (phenotype), gene AIFM1 OMIM 300169; Orphanet lists it as a rare CMT/Cowchock entity; MeSH maps to Charcot-Marie-Tooth Disease (D002607) with X-linked qualifiers; ICD-10 G60.0 (hereditary motor and sensory neuropathy). Synonyms: Cowchock syndrome; CMT4X; X-linked motor-sensory neuropathy type II with deafness and mental retardation. Information is derived from aggregated disease-level resources and small family case series, not EHR/individual-patient registries.

2. Etiology

Causal factor: monogenic — hemizygous missense variants in AIFM1 (Xq26.1). Genetic risk: being hemizygous male for a pathogenic AIFM1 allele confers disease; female carriers are usually unaffected but may manifest with skewed X-inactivation. No environmental risk factors are established for the human disease, though model data show AIF deficiency sensitizes neurons to environmental complex I toxins (MPTP) — a demonstrated gene–environment interaction (PMID: 20695011). No protective alleles or environmental protective factors are documented. Consanguinity is not required (X-linked). No infectious etiology.

3. Phenotypes

Phenotype Type HPO Onset Severity/Progression Frequency
Distal weakness & atrophy Physical/motor HP:0007107 / HP:0003693 Infancy–childhood Severe, progressive Core (near-universal in males)
Distal sensory loss Sensory sign HP:0002936 Childhood Progressive High
Areflexia Clinical sign HP:0001284 Early Stable/progressive High
Pes cavus / hammer toes Skeletal HP:0001761 / HP:0001765 Infancy Progressive High
Sensorineural (auditory neuropathy) deafness Lab/clinical HP:0000407 Variable Variable/progressive 5/7 in original family (~70%)
Cognitive impairment Behavioral/cognitive HP:0001256 Childhood Stable 3/5 in original family (~60%)
Cerebellar ataxia Clinical sign HP:0001251 Variable Progressive Frequent in expanded families
Pyramidal signs Clinical sign HP:0007256 Variable Progressive Frequent
Color-vision deficiency Sensory HP:0000551 — Stable 3/7 (Irish family)
Tremor Clinical sign HP:0001337 Variable Progressive Subset

Quality-of-life impact is dominated by loss of ambulation (foot deformity, distal weakness), communication difficulty (deafness), and, in a subset, tremor-related disability responsive to DBS (PMID: 36907087).

4. Genetic/Molecular Information

Causal gene: AIFM1 (HGNC:8768; Xq26.1; OMIM 300169). Reported pathogenic/likely-pathogenic variants (all missense, germline, hemizygous): c.1478A>T p.Glu493Val (founding Cowchock variant, PMID: 23217327); c.1006G>A p.Glu336Lys (PMID: 41957773); c.513G>A p.Met171Ile (ACMG likely pathogenic, PMID: 30031633); p.Asp237Gly (SEMD-neurodegeneration, PMID: 27102849); c.506C>T p.Pro169Leu (manifesting female, PMID: 42329587); c.5T>C p.Phe2Ser (neonatal, targeting sequence, PMID: 37644805). Variant class: predominantly missense (± one intronic/splice variant reported in the broader spectrum). Functional consequence: protein destabilization with altered redox properties and weakened AIF:CHCHD4 interaction — a partial loss of function with a pro-apoptotic gain of harmful activity. Allele frequencies in gnomAD are effectively absent/ultra-rare, consistent with high pathogenicity. No recurrent modifier genes are established, though CHCHD4/MIA40 abundance is mechanistically downstream. Epigenetic contributions to disease are limited to skewed X-inactivation modulating female expression.

5. Environmental Information

No environmental, lifestyle, or infectious factors cause CMTX4 in humans. The only relevant environmental interaction is experimental: AIF-deficient neurons are hypersensitive to the mitochondrial complex I neurotoxin MPTP, reversible by the antioxidant tempol (PMID: 20695011).

6. Mechanism / Pathophysiology

Causal chain: AIFM1 missense variant → reduced AIF protein stability (mRNA preserved) → compromised FAD retention and altered NAD(H) redox switch → weakened charge-transfer complex and loss of the AIF:CHCHD4/MIA40 interaction → impaired mitochondrial intermembrane-space import and defective assembly of respiratory complex I and supercomplexes → decreased basal respiration, reduced mitochondrial content, and a shift toward apoptotic cell death → length-dependent axonal degeneration of peripheral sensory/motor neurons, degeneration of auditory neurons, and central neuronal loss (cerebellum, thalamus, striatum, cortex) → clinical neuropathy, deafness, ataxia, and cognitive impairment. Upstream = AIF destabilization/redox defect; downstream = complex I/supercomplex failure and neurodegeneration (PMID: 23217327; PMID: 41957773; PMID: 32769219). Cell types: peripheral sensory/motor neurons and their long axons, cochlear/auditory neurons, cerebellar neurons; Schwann cells are relatively spared (axonal, not demyelinating). Subcellular compartment: mitochondrion / intermembrane space (GO:0005758), inner membrane (GO:0005743). Biochemical defect: FAD/NAD(H) oxidoreductase dysfunction.

7. Anatomical Structures Affected

Primary: peripheral nerves (UBERON:0001021), especially long, distal, large-fibre motor and sensory axons of the lower limbs (bilateral, length-dependent, symmetric). Secondary/associated: cochlea and auditory pathway (UBERON:0001844), cerebellum (UBERON:0002037), corticospinal/pyramidal tracts, and cerebral cortex (cognitive involvement). Body systems: peripheral and central nervous system; musculoskeletal (secondary foot deformities). Cell level: neurons (CL:0000540) and their axons; auditory neurons/inner hair cells. Subcellular: mitochondria (GO:0005739).

8. Temporal Development

Onset: typically infancy to childhood in the classic form, but the expanded spectrum spans 18 months to ~39 years (PMID: 31523922). Onset pattern: insidious, chronic. Course: slowly progressive, chronic and lifelong; no relapsing-remitting pattern and no spontaneous remission. Progression rate is variable, ranging from mild neuropathy to wheelchair dependence and respiratory involvement in severe intrafamilial cases (PMID: 39601015).

9. Inheritance and Population

Inheritance: X-linked recessive; affected hemizygous males, carrier females usually asymptomatic but occasionally manifesting via skewed X-inactivation (PMID: 42329587). Penetrance: high in hemizygous males; expressivity: highly variable, even within families. No genetic anticipation (not a repeat-expansion disorder). Epidemiology: no CMTX4-specific prevalence figure; it is an ultra-rare subtype within CMT (overall CMT prevalence 4.7–36/100,000; PMID: 20929675). Sex ratio: strongly male-predominant. Families reported are geographically diverse (US, Ireland, China, Italy) with no established founder effect.

10. Diagnostics

Electrophysiology: nerve conduction studies show axonal sensorimotor neuropathy (large-fibre, length-dependent) with markedly abnormal sensory responses; audiology/ABR shows auditory-neuropathy pattern. Imaging: calf MRI shows fatty infiltration of the peroneal compartment (PMID: 30031633); brain MRI may be normal or show mild cerebellar atrophy. Pathology: nerve/muscle biopsy shows abnormal mitochondrial morphology and accumulation (PMID: 30031633). Genetic testing: exome/genome sequencing or a comprehensive inherited-neuropathy NGS panel is the definitive route (PMID: 32506583); single-gene AIFM1 testing confirms known familial variants. Differential diagnosis: CMTX1 (GJB1), other CMT2 subtypes, mitochondrial neuropathies, and syndromic deafness-neuropathy conditions; the combination of axonal neuropathy + auditory neuropathy + ataxia + X-linked male-limited inheritance is the diagnostic signature.

11. Outcome / Prognosis

CMTX4 is a chronic, progressive but generally non-fatal neurodegenerative condition; life expectancy is not markedly reduced in the classic form, though the severe end of the AIFM1 spectrum (infantile encephalomyopathy, respiratory failure) carries high mortality. Morbidity is driven by progressive disability from distal weakness, sensory loss, hearing impairment, and ataxia; some patients progress to wheelchair dependence and respiratory compromise (PMID: 39601015). No validated CMTX4-specific prognostic biomarkers exist; disease severity correlates broadly with the specific AIFM1 variant and, in females, with the degree of X-inactivation skewing.

12. Treatment

No disease-specific/curative therapy exists (PMID: 19539237). Supportive/rehabilitative: ankle-foot orthoses, physical and occupational therapy, orthopedic surgery for pes cavus/hammer toes, mobility aids. Sensory: hearing aids or cochlear implants for the auditory-neuropathy component. Tremor: DBS of the ventral intermediate thalamic nucleus for treatment-resistant AIFM1-related tremor (PMID: 36907087). Established CMT1A experimental drugs (ascorbic acid, curcumin, antiprogesterone) are mechanistically inapplicable to axonal AIFM1 disease. Redox-protective compounds (methylene blue, tempol) are promising only at the preclinical/model stage (PMID: 30300862; PMID: 20695011).

13. Prevention

No primary prevention. Secondary/tertiary prevention: cascade genetic testing of at-risk relatives, early audiologic and neurophysiologic surveillance, and proactive management of foot deformities and hearing loss. Reproductive prevention: genetic counseling, preimplantation genetic testing of IVF embryos, and prenatal diagnosis once the familial AIFM1 variant is known (PMID: 37173762), with counseling that accounts for potential manifesting female carriers.

14. Other Species / Natural Disease

The mouse ortholog Aifm1 (NCBI Gene 26926) underlies the naturally arising Harlequin (Hq) mouse mutant, the principal comparative model. No naturally occurring companion-animal or wildlife equivalent of CMTX4 is catalogued in OMIA at the level documented here. AIF is evolutionarily conserved (a FAD/NADH oxidoreductase with orthologs across metazoans), supporting cross-species mechanistic conservation. No zoonotic relevance.

15. Model Organisms

The Harlequin mouse (proviral insertion reducing Aif ~80%) is a spontaneous mammalian model recapitulating complex I deficiency, cerebellar and multifocal neurodegeneration, retinal degeneration, and neurotoxin susceptibility (PMID: 17805014; PMID: 19280713; PMID: 30300862; PMID: 20695011). Patient-derived fibroblasts provide a cellular model demonstrating AIF destabilization, CHCHD4 loss, and impaired respiratory-supercomplex assembly (PMID: 41957773). Limitations: the Hq mouse is a knockdown (loss-of-expression) rather than a knock-in of specific human missense variants, so it models AIF deficiency more than the redox-shift mechanism of CMTX4; it also emphasizes central/retinal phenotypes over the human peripheral-neuropathy-plus-deafness presentation.

Mechanistic Model / Interpretation

   AIFM1 missense variant (e.g., p.Glu493Val, p.Glu336Lys, p.Met171Ile)
              |
              v
      Reduced AIF protein stability (mRNA preserved)
      Compromised FAD retention; impaired NADH affinity
              |
              v
   Destabilized FADH2-NAD charge-transfer complex  <-- redox switch broken
              |
      +---------------+----------------+
      v                                v
  Weakened AIF:CHCHD4/MIA40 interaction    Shift toward pro-apoptotic state
  (impaired IMS protein import)            (increased caspase-independent
      |                             cell death)
      v                                |
  Defective complex I / respiratory           |
  supercomplex assembly; low mito content     |
      |                                |
      +---------------+----------------+
              v
       Mitochondrial dysfunction in long-axon neurons,
       auditory neurons, cerebellar/central neurons
              |
              v
   Length-dependent axonal neuropathy + auditory-neuropathy deafness
   + cerebellar ataxia + pyramidal signs + cognitive impairment + tremor

The unifying theme is that AIF is a redox-controlled hub linking mitochondrial biogenesis (complex I assembly via CHCHD4 import) to programmed cell death. CMTX4 variants tip this balance: they are severe enough to destabilize the protein and impair its import/assembly function, yet (in the classic phenotype) mild enough to avoid the catastrophic OXPHOS collapse that characterizes the infantile-encephalopathy end of the AIFM1 allelic spectrum. Neuronal vulnerability is greatest in cells with the highest metabolic and axonal-transport demands — long peripheral axons, auditory neurons, and cerebellar circuits — explaining the characteristic clinical triad. Variant severity plus (in females) X-inactivation skewing accounts for the striking phenotypic range from mild neuropathy to lethal encephalomyopathy.

Evidence Base

PMID Title (abbrev.) Role in this report
23217327 Cowchock syndrome is associated with a mutation in AIF Founding causal-gene identification; redox mechanism without OXPHOS failure
8666389 Locus maps to Xq24-q26 Original linkage mapping of the CMTX4 locus
3856385 X-linked MSN type-II with deafness and MR Original clinical description of core phenotype
31523922 Clinical spectrum in an Irish family Expanded phenotype (ataxia, pyramidal, color blindness)
37173762 Novel AIFM1 variant, Han-Chinese family Diagnostics + reproductive prevention utility
30031633 Novel AIFM1 mutation, Chinese family (CMT4X) Biopsy mitochondrial pathology, calf MRI, ACMG classification
41957773 E336K mutation, mitochondrial dysfunction Refined mechanism: AIF destabilization, CHCHD4 loss, supercomplex defect
32769219 AIF redox-controlled gear boxes AIF role in CHCHD4/MIA40 import and complex I assembly
20868295 AIF: structure, function, redox regulation AIF dual redox/respiratory-assembly role
19447115 Redox-linked conformational dynamics in AIF Structural basis of the redox switch perturbed by mutations
26535916 Adenylate moiety and NAD(H) binding to AIF Pathological-equivalent mutation effects on NAD(H) binding
17805014 AIF deficiency, mitochondrial degeneration Harlequin mouse neurodegeneration pattern
19280713 ROS regulation in AIF-/complex I-depleted mito Hq complex I deficiency quantification
30300862 AIF deficiency, retinal degeneration, methylene blue Model retinal phenotype; candidate redox therapy
20695011 AIF deficiency sensitizes DA neurons to neurotoxins Gene–environment interaction; tempol rescue
36907087 DBS for AIFM1-related tremor Effective symptomatic intervention for tremor
19539237 Diagnosis, natural history, management of CMT No drug therapy; supportive-care standard
18334132 Charcot-Marie-Tooth disease Multidisciplinary management framework
36751702 Auditory neuropathy spectrum disorder Links AIFM1 to ANSD (DFNX5) mechanism
20929675 CMT: an update Overall CMT prevalence context
20571287 CMT in Cyprus Population-based CMT prevalence example
32506583 Diagnostic yield of NGS panels NGS/exome as diagnostic route for axonal CMT
27102849 SEMD with neurodegeneration, AIFM1 Allelic spectrum (skeletal + neurodegeneration)
26173962 AIFM1 infantile motor neuron disease Allelic spectrum (motor neuron involvement)
39601015 Novel AIFM1 variant, siblings Intrafamilial variability; ataxia + auditory neuropathy
37644805 Neonatal-onset AIFM1 disorders Allelic spectrum; CMT4X-to-encephalopathy statement
42329587 Female child with heterozygous AIFM1 variant Manifesting female via skewed X-inactivation

Limitations and Knowledge Gaps

  1. No CMTX4-specific epidemiology. Prevalence, incidence, sex-stratified age distribution, and geographic/founder patterns are unknown; the disease is described only in scattered small families, so all population statements are extrapolated from the broader CMT literature.
  2. Genotype–phenotype correlation is incomplete. Why some AIFM1 variants produce mild CMTX4 while others cause lethal encephalopathy is not fully resolved; systematic biophysical characterization exists for only a few variants (e.g., E493V, E336K).
  3. Human mechanistic data are limited to a handful of patient fibroblast studies; the dominant animal model (Harlequin) is a knockdown, not a knock-in of human CMTX4 missense alleles, and emphasizes central/retinal over peripheral phenotypes.
  4. No natural-history study or validated outcome measures specific to CMTX4; progression rates, disability trajectories, and prognostic biomarkers are anecdotal.
  5. No therapeutics targeting the AIF:CHCHD4 axis have been tested in humans; redox-protective compounds are only preclinical.
  6. Female carrier risk quantification is poor — the frequency of manifesting carriers and the X-inactivation thresholds for symptom emergence are undefined.

Proposed Follow-up Experiments / Actions

  1. Establish a CMTX4/AIFM1 patient registry to define natural history, penetrance, sex ratio, and genotype–phenotype correlations, using standardized CMTNS and SARA scores plus audiometric/ABR endpoints.
  2. Generate knock-in mouse or iPSC-derived motor/sensory neuron models carrying specific human CMTX4 variants (e.g., p.Glu493Val, p.Glu336Lys) to model the redox-shift mechanism rather than mere AIF deficiency, and to compare peripheral vs. central vulnerability.
  3. Systematic biophysical variant panel: express and purify a series of reported AIFM1 missense proteins to quantify FAD retention, NADH affinity, charge-transfer stability, and CHCHD4 binding, building a predictive severity scale for VUS classification.
  4. Test AIF:CHCHD4-restoring or redox-stabilizing therapeutics (e.g., methylene blue, tempol, FAD-supporting agents, CHCHD4 overexpression) in patient fibroblasts and neuron models for rescue of respiration/supercomplex assembly.
  5. Characterize the auditory-neuropathy phenotype prospectively to define optimal timing and outcomes of cochlear implantation in CMTX4 patients.
  6. Quantify female-carrier risk by correlating X-inactivation ratios with clinical status across carrier cohorts, to refine genetic counseling.
  7. Evaluate DBS more broadly for AIFM1-related tremor with prospective multi-patient outcome data, given the encouraging case series.

Evidence source types: human clinical (family case series, patient fibroblasts), model organism (Harlequin mouse), in vitro biochemistry/structural biology, and computational variant prediction. This report is compiled from disease-level resources and primary literature; it does not derive from individual EHR data.

Artifacts